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    The n on - apoptotic function  of   Caspase - 8  in  endothelial precursor cells     Dissertation   zur Erlangung  des Doktorgrades    der Naturwissenschaften     vorgelegt beim Fachbereich Biowissenschaften   der Johann Wolfgang Goethe - Universität   in Frankfurt am Main       Dörte Scharner   born  in Stralsund/ Mecklenburg - Vorpommern       Frankfurt ,  200 9      Die  nicht - apo p totische  Funktion    von Caspase - 8 in endothelialen  Vorläuferzellen     Dissertation   zur Erlangung des Doktorgrades    d er Naturwissenschaften     vorgelegt beim Fachbereich Biowissenschaften   der Johann Wolfgang Goethe - Universität   in Frankfurt am Main     von    Dörte Scharner   geboren in Stralsund/ Mecklenburg - Vorpommern       Frankfurt 200 9            Vom Fachbereich Biowissenschaften der G oethe Universität als  Dissertation angenommen       Dekan : Herr Prof essor  Dr. Volker Müller       1.Gutachter: Frau  Prof essorin  Dr. Anna Starzinski - Powitz   2.Gutachter: Frau Prof essorin  Dr. Stefanie Dimmeler           Datum der Disputation:   20.Juli 2009Danksagung   An  d ieser  Stelle  möchte  ich  denjenigen  danken,  die  mir  mein  Studium  und  die  Promotion ermöglichten und  jederzeit unterstützend  beiseite standen.   Für  die  Bereitstellung  des  interessanten  Themas  und  den  hervorragenden  Arbeitsbedingungen möchte ich Frau Prof. Dr.  Stefanie Dimmeler und Herrn Prof. Dr.  Andreas Zeiher danken. Weiterhin möchte  ich  PD Dr. med. Lothar Rössig für die  zahlreichen wissenschaftlichen Diskussionen und die Unterstützung zum Gelingen  dieser Arbeit danken.    Weiter hin gilt großer  Dank meinen Kol legen und gleichzeitig Freunden Dr. Angelika  Bonauer, Ariane Fischer, Dr. Guillaume Carmona, Dr. Alessia Orlandi und Carmen  Döbele für die wissenschaftliche Diskussionen während der Entstehung der Arbeit  als  auch  die  Teilhabe  in  anderen  Lebenslagen  innerha lb  und  ausserhalb  dieser  Arbeitszeit.   Ich  danke  dem  gesamten  Team  der  molekularen  Kardiologie  bestehend  aus  technischen  Assistenten,  Doktoranden  und  Post - Docs  für  die  schöne  3 - jährige  Laborzeit, die auch ab und an andererorts ausgeklungen ist, was wiederum  die gute  Teamfähigkeit und den Zusammenhalt der Arbeitsgruppe zeigt.   Hierbei  möchte  ich  mich  weiterhin  besonders  bei  dem  „tierischen“  Team  Ariane  Fischer,  Marion  Muhly - Reinholz  und  Tino  Röxe  für   ihre  Geduld  und  Aufopferung  bedanken.    Desweiteren  danke  ich   Dorit  Lüthje,  Tina  Rasper  und  Carmen  Schön  für  ein  angenehm entspanntes, freundschaftliches und motivierendes Laborklima , wo auch  immer  ein  paar  Scherze  den  Laboralltag  erheiterten .   Nicht  zuletzt  sollen  Andrea  Knau, Nicole Konecny und Natalja Reinfeld erw ähnt werden für ihre zu jeder Zeit  hilfsbereite Art in bester Laune.   Meiner Familie danke ich für die ständige finanzielle und seelische Unterstützung  während meiner gesamten Ausbildungszeit, gefolgt von  Aufmunterungen, viel Liebe  und der Glauben an mich  a uch  in seelisch schweren Zeiten.    Meinem Schatz Torben danke ich für seine Geduld und  die vielen  Aufmunterungen in  der wenigen Zeit, die wir an den Wochenenden  während dieser Arbeit  miteinander  hatten.      i     Contents   1.   Introduction ................................ ................................ ............................... 1   1.1   Vasculogenesis, Angiogenesis and Arteriogenesis ................................ .... 1   1.1.1   Vasculogenesis ................................ ................................ ....................... 1   1.1.2   Angiogenesis ................................ ................................ ........................... 2   1.1.3   Arteriogenesis ................................ ................................ ......................... 4   1.2   Structure and maturation of blood vessels ................................ .................. 4   1.3   Endothelial precursor (progenitor) cells ................................ ...................... 5   1.4   Endothelial pre cursor (progenitor) cells for therapeutic use ........................ 7   1.5   EPC function in diseases ................................ ................................ ............ 8   1.6   Caspases and their function ................................ ................................ ....... 8   1.7   Non - apoptotic functions of caspases ................................ ........................ 11   1.8   Caspase - 8 ................................ ................................ ................................ 12   1.9   Integrins and t heir function in vasculogenesis and angiogenesis ............. 13   1.10   Cbl - b, an E3 ubiquitin ligase ................................ ................................ ..... 15   1.11   Aim of this study ................................ ................................ ......................... 1   2.   Materials and Methods ................................ ................................ ............. 2   2.1   Cells ................................ ................................ ................................ ............ 2   2.2   Cell culture of HUVEC, HMVEC and H EK293T ................................ .......... 2   2.3   Isolation  and  ex  vivo   endothelial  differentiation  of  human  endothelial  progenitor cells (EPC) ................................ ................................ ................. 4   2.4   Isolation of EP Cs from mouse spleen  -  EPC - assay ................................ .... 4   2.5   Gene knockdown by RNA interference (siRNA - mediated) .......................... 5   2.6   RNA isolation ................................ ................................ .............................. 6   2.7   Oligonucleotide microarrays (Affymetrix, Inc.) ................................ ............ 6    ii     2.8   RT - PCR ................................ ................................ ................................ ...... 7   2.9   Plasmid t ransfection in HUVEC and HEK293 using Superfect (Qiagen) .... 8   2.10   Lentivirus - transduction in HUVEC and EPC ................................ ............... 9   2.11   Protein isolatio n from whole cells ................................ ................................ 9   2.12   Immunoprecipitation ................................ ................................ .................. 10   2.13   Colorimetric analyses of protein concentration according to Bradford ...... 10   2.14   SDS - polyacrylamid gel electrophoresis (SDS - PAGE) ............................... 10   2.15   Wet - blot method for specific protein detection (Western blot) ................... 11   2.16   Adhesion assays ................................ ................................ ....................... 12   2.17   EPC and HUVEC migration assay ................................ ............................ 13   2.18   “Scratch wound” assay ................................ ................................ ............. 13   2.19   Spheroid assay ................................ ................................ ......................... 14   2.20   Detection of proteins in whole cells by fluorescence microscopy .............. 15   2.21   Fluorescence activated cell sorting (FACS) of EPCs and mice bone marrow  cells ................................ ................................ ................................ ........... 15   2.22   Apoptotic measurement of endothelial precurso r cells with Annexin V (BD  Pharmingen) ................................ ................................ ............................. 16   2.23   Caspase activity analysis ................................ ................................ .......... 17   2.24   Murine ischemic hind limb model and BMC transpl antation ...................... 17   2.25   Immunohistochemistry ................................ ................................ .............. 18   2.26   Matrigel plug assay ................................ ................................ ................... 18   2.27   Statistical analysis ................................ ................................ ..................... 19   3.   Results ................................ ................................ ................................ ..... 20   3.1   Caspases in endothelial precursor cells ................................ .................... 20   3.2   Caspase - 8 expression in human cells ................................ ...................... 22    iii     3.3   Caspase - 8 activity is required for pro - angiogenic cell function  ex vivo ..... 23   3.4   Caspase - 8 inhibition plays a role in cytokine release ............................... 26   3.5   The activity of caspase - 3 is not increased in adherent EPC ..................... 27   3.6   In  vivo   incorporation  and  improvement  of  neovascularization  by  transplanted human outgrowing precursor cells is reduced by caspase - 8  inhibition ................................ ................................ ................................ .... 30   3.7   Caspase - 8  def iciency  in  vivo   reduces  functionality  and  vascularization  capacity of bone marrow mononuclear cells ................................ ............. 32   3.8   Cell surface receptor regulation by caspase - 8 inhibition ........................... 39   3.9   Caspase - 8 targets Cbl - b ................................ ................................ ........... 43   3.10   Cbl - b influences angiogenesis ................................ ................................ .. 48   3.11   Cbl - b in vascul arization in vivo ................................ ................................ .. 50   3.12   Regulation of Caspase - 8 ................................ ................................ .......... 52   4.   Discussion ................................ ................................ ............................... 54   4.1   Characterization of endothelial progenitor cells ................................ ........ 54   4.2   Selection of Caspase - 8 as an important player in EPC function ............... 55   4.3   Low Caspase - 8 expression in HUVEC ................................ ..................... 56   4.4   Non - apoptotic function of Caspase - 8 ................................ ........................ 57   4.5   Cell adhesion and migration in the pr esence of caspase - 8 inhibitor is due to  transmembrane molecule reduction ................................ .......................... 58   4.6   Growth factor production is influenced indirectly by caspase - 8 ................ 60   4.7   Caspase - 8 inhibition in EPC impedes neovascularization ........................ 60   4.8   Cbl - b is a novel target of caspase - 8 ................................ ......................... 61   4.9   Cbl - b inhibition promotes angiogenesis in vitro and in vivo ....................... 63   4.10   Non - apoptotic caspase - 8 regulation in EPC ................................ ............. 65   5.   Conclusion ................................ ................................ .............................. 67    iv     6.   Abbreviations ................................ ................................ .......................... 69   7.   Bibliography ................................ ................................ ............................ 71    1. Introd uction     1     1.   Introduction   The vascular system  is a network of vess els that  carries blood and l ymph through the  body .  The system can be  divided  i nto  different parts : heart, macro - circulation, micro - circulation and lymph vascular system.   The   vessels  of   the blood circulatory system  are divided into arteries, veins and capil laries.  The artery blood vessels carry  oxygen - saturated  blood  and nutr ient s  from  the heart to the body. The venous system  carr ies   deoxygenated blood from the body back to the heart and lung to be released as  carbon dioxide. The small capillaries between ar teries and veins provid e  nutrients ,  immune cells  and oxygen to  every cell in  the surrounding tissue   as well as  transport  waste products and pick up carbon dioxide to secrete it from the body.   The essential  oxygen and  carbon dioxide are exchanged through th e respiratory system.      1.1   Va s culogenesis ,   Angiogenesis  and Arteriogenesis   A rteries ,   veins   and  capillaries   form  a  complex  network  of  branched  structures  in  adult s . The development of this network  is mediated by three different processes :  vasculogenesis,  angio genesis, and arteriogenesis.     1.1.1   Vasculogenesis   The early stage of blood vessel formation is called vasculogenesis.  During embryonic  development,  undifferentiated  precursor  cells,  so - called  hemangioblast s   form  aggregates  and  differentiate  into  hematopoietic  precursors  and  endothelial  cells   (ECs)   to form a  primitive  vascular  network  of small capillaries , the vascular plexus   (Choi,  Kennedy  et  al.  1998) ,  reviewed  in   (Carmeliet  2000) .  Va s cular  endot h elial  growth factor (VEGF, also known as  KDR  or Flk1 )  and basic fibroblast growth factor  (bFGF) stimulate the differentiation of endothelial cells into  arterial and venous ECs.  This fate of endothelial precursor cells to become integrated into arteries or  veins is  further supported by  gene  members of the Notch family,  the  Hox  (Homeobox)   family  and  members  of  GATA  and  ephrin  family  (Gale  and  Yancopoulos  1999) .  For 1. Introd uction     2     instance,  mutations  of   Notch  ligand  delta - like  (DLL)4  lead s   to  a  defect ive   arterial  development and upregulation of venous markers  (Duarte, Hirashima et al. 2004)   (Krebs, Shutter et al. 2004) .  Vessel growth , however,  is not on ly restricted to the  embryo.  Endothelial precursors contribute to blood vessel growth also in ischemic,  inflam m ed  an d  malignant  tissue  in  t he  adult.  For  example,  endothelial  precursor  cells,  mesoangioblasts  and  multipotent  adult  precursors  in  the   bone  marr ow  and  peripheral  blood  are  stimulated   for  mobilization  and  differentiation  by  VEGF,  placental  growth  factor  (P L GF),  angiopoietin  (Ang) - 1  and  cytokines  to  support  vasculogenesis of  new  blood vessels  (reviewed  (Carmeliet 2003) ).       1.1.2   Angiogenesis   R emodelling,  sprouting   and branching  from  pre - existing vessels  to new capillaries  is  defined  as  angiogenesis.   Different  mechanism s   like  activation,  migration  and  proliferation of endothelial cells   and endothelial proge nitor cells  are involved in th is   angiogenic process  forming a higher organized and stereotyped vascular network .   S ignalling  through  the  hypoxia - inducible  transcription  factor  (HIF)  induces  vasodilation  of  the  vessels  and  upregulates   angiogenic  genes  like  V EGF ,  angiopoietin - 2,  nitric  oxide  syntha se,  TGFβ - 1,  interleukin - 8  and  Tie1  which  are  crucial  for  cardiovascular  homeostasis   by  supporting  endothelial  cell  proliferation ,  migration and expression of adhesion molecules.   (Carmeliet 2000 )   (Carmeliet 2003)   (Aicher, Heeschen et al. 2003)   (Carmeliet 2005) .   The p artial knockout of the VEGF  gene lead s  to  a  vascular defect resulting in embryonic lethality   (Carmeliet, Ferreira et  al. 1996)   (Ferrara, Carver - Moore et al. 1996) .   Furthermore,  ECs communicate within  the  vessel  wall .    B lood  flow  and  increase  in  blood  pressure  lead  to  interactions  between the cytoskeleton of ECs  and the surrounding extracellular  matrix (ECM).   ECs start to migrate and adhere at different places.  Sprouting and remodelling of  vessels  causes  remodelling  of  ECM  by  proteinases  like  plasminogen  activators,  matrix metalloproteinases (MMPs) and cathepsins.  Vessel   s tabilization is reached b y  recruiting  mural  cells  ( smooth  muscle  cells  and  pericytes)  which  are  activated  by   shear   stres s  r esponsive gene transcription , Tie - 2 receptor, PDGF, TGF - β and PIGF  1. Introd uction     3     (Carmeliet 2003) .  Some processes  of  vascular embryonic development tak e  place in  neoangiogenesis in  the  adult or as neovascularization  in  injured or ischemic tissue  (Carmeliet 2003) .  Insufficient or abnormal vessel growth can cause many diseases  like hypertension, neuro degeneration and osteroporosis.       Figure  1.2.1:  Vascular  network  formation  by  vasculogenesis,  a ngiog enesis  and  arteriogenesis   Endothelial progenitor cells from a common hemangioblast form a  primitive vascular  capillary  plexus after differentiation into  arterial and venous ECs  dependent on the stimuli. This early  process  is  called  vasculogenesis.  Smooth  m uscle  cells  surround  sprouting  vessels  for  stabilization. Hematopoietic stem cells support angiogenesis by releasing angiogenic factors,  differencing into various cell types and endothelial cells  (Carmeliet  2003) .    1. Introd uction     4     1.1.3   Arteriogenesis   Arter i ogenesis  is  a  consequence  of  physical  forces   such  as  longitudinal,  circumferential  and  radial  wall  stress   caused  by  increased  blood  pressure   (Heil,  Eitenmuller  et  al.  2006) .  Smooth  muscle  cell  proliferation,  differentiation   and  migration   increases  collateral growth  and results in  sprouting and migration  alongside  pre - existing vessels.  Chemoattracted monoc ytes adhere within the collateral wall  to   support remodelling and proliferation of vascular wall cells . E ventually , they  are  also   important for processes  in arteriogenesis  (Carmeliet 2003)   (Heil, Eitenmuller et al.  2006) .      1.2   Structure  and maturation  of blood vessels   As  previously  mentioned,  d uring  embryonic  development   the  nascent  vascu lar  capillary  network  develops  by   vasculogenesis  and   angiogenesis.   N ascent  and  mature vessel s   differ  in   capillar y  (small), arter y  and vein (big vessels )   morphology .  Vessel  d evelop ment  starts  with   a  channel   of  ECs   (Fig.1.3.1 a) .  Th ese   nascent  c apillaries  con sist of the EC tube surrounded by a thin layer of pericytes which are  enveloped by an EC basement membrane  (Fig.1.3.1 b) .  The arterial - venous fate is  influenced  by  the  local  metaboli sm   ( e.g.  hypoxia,  pH)  and  the  mechanical  environment ( e.g.  shear stress, hy drostatic pressure).  Pericytes  and vascular  SMCs  cover  the  basal  capillary  structure  embedded  into  elastic  lamina  and  basement  membrane (Fig. 1.3.1c ).  In order  to  tissue   and organ   specificity ,   the walls are divided  into  three  layers. The inner part , the so - called intima  is based  on ECs. SMCs form  the  media,  whereas  the  outer  adventitia  is  composed  of  fibroblasts,  extracellular  matrix and elastic  lamina  (Fig.1.3.1d).  Com m unication between EC s  and   as well as  EC s  and  surrounding mural  cells  is mediated by gap j unctions, cadherins and tight  junctions , which  are also important for the tissue - blood - barrier in  brain and retina  (Jain 2003) .    1. Introd uction     5       F igure  1.3.1 :  Vessel maturation during different stages in  development   (a) New developing vessels consist of  a  monolayer of endothelial cells. At this point, they  further expand into capillaries, arteries or veins. (b) Capillaries, based on the endothelial  tube  (a), are surrounded by a  thin layer of pericytes embedded into a  basement membrane.  This   kind   of  vessel  structure  is  involved  in  import  and  export  between  blood  and  tissue  (c )  Developing  arterioles and venules are covered with vascular smooth muscle c ells  carrying  their own basement membrane and are  e mbedded into an external elastic lamina. (d) Larger  vessels are  made  of three layers: intima, media and adventitia.   Modified after   (Jain 2003)     1.3    Endothelial  precursor ( progenitor )  cells    The existence of so - called endothelial precursor (progenitor) cells was first described  by  Asahara  and  co - workers.  T hey  isolated  putative  CD34 +   endoth elial  progenitor  cells from human peripheral blood using magnetic microbeads   (Asahara, Murohara  et al. 1997) .  After e x vivo cult ivation  on f ibronectin   matrix, this heterogeneous  ce ll  1. Introd uction     6     population  differentiat es   into cells with endothelial character   expressing endothelial  markers  li ke  CD133,  CD34  and  the  VEGFR - 2   (Peichev,  Naiyer  et  al.  2000) .   In  general, c ells which express CD133, a hematopoieti c stem cell marker, are mainly  localised in the bone marrow   (Yin, Miraglia et al. 1997)  and show no expression of  vascular  endothelial  cadh erin  and  von Willebrand  factor.  Further more ,  they  found  more  matu re  and  differentiated  EPCs  in  the  pheripheral  circulation   of  adults   but  missing  CD133 surface expression.  It is conseivable that t hese cells have their origin  in the bone marrow  (Shi, Rafii et al. 1998)  lo o sing  the marker  CD133  probably  during  transmigration  into  the  blood  circulation .   These  c irculating  EPC s   lacking   CD133 ,  expre ss C D34, VEGFR - 2, CD31, VE - cadherin,  von Willebrand factor  and incorporate  Dil - Ac - LDL .  These findings support ed   the assumption that EPC s  are bone marrow - derived  with  a  hemangioblast  origin   (Loges,  Fehse  et  al.  2004) ,  migrate  into  the  circulating blood system and differentiate further to cells with endothelial character.   But EPC  were  also isolated from fetal liver or umbilical cord blood  (Yin, Miraglia et al.  1997)   ( Murohara, Ikeda et al. 2000) .  The  number  of CD133 +  cells in  the  blood can be  increased by m obiliz ing   cells  from the bone marrow  by  injection of g r anulocyte colony  stimulating factor (G - CSF)  (Peichev, Naiyer et al. 2 000) .   In addition,  it was shown   that  these   CD133 +   cell  populations   are  able  to  differentiate  into  a  hematopoietic  lineage and into endothelial cells  in the presence of the cytokines VEGF and  stem  cell  growth  factor  (SCGF)   (Gehling,  Ergun  et  al.  2000) .  Becau se  the  definition  of  EPC s  has a wide range and differs between  different  investigator   groups,  there have  been efforts  to define the heterogeneity  in more detail  and  to  distinguish between   early and late EPC s   (Gulati,  Jevremovic et al. 2003)   (Hur, Yoon et al. 2004) .  Hur et.  al   isolated  total  mononuclear  cells  from  human  blood  and  gained  early  spindle  shape d   EPC s   with  a  lifespan of  4  weeks  as  well  as  late  outgrowth  EPC s   with  a  p aving stone structure and a life expectancy up to 12 weeks. Furthermore, these two  population s   differ  in  secretion  of  angiogenic  cytokines,  surface  marker  expression  and  in  ex  vivo   assay   outcomes   but   show  similarity   in  their  in  vivo   vasculogenic  capacity .   However, so far  there is no clear definition for EPC s  from peripheral blood .   In summary, e ndothelial precursor cells  are a   mixture  of cells with a high variety in 1. Introd uction     7     diffe rentiation, strongly dependent on the isolation protocol as well as  ex vivo  cell  culture  conditions   (Seeger, Tonn et al. 2007) .      1.4   Endothelial  precursor (progenitor)  cells for therapeutic use   During  the last decade,  experimental investigati ons  have demonstrated that  EPC s   improve  neovascularisation   (Rafii  and  Lyden  2003) .  Cell  therapy  is  a  promising  option  to  enhance  endothelial  repair  and  tissue  perfusion  after  ischemia.  Tr ansplantation of human EPC s  into  nude mice  enhanced the b lood flow recovery  and capillary density  with in the  hind   limb ischemic area   (Kalka, Masuda et al. 2000)   as well as myocardial neovascularization and improved left  ventricular function  after   myocardial infarction  (Kawamoto, Gwon et al. 2001) .  Additional  mouse  experiments  have proven  that EPC s   in  the blood  are  mobilized from the bone - marrow by  ischemic  events or  are  attracted by cytokines like GM - CSF (granulocyte macrophage -  colony  stimulating  factor) .  Accord ingly ,  m obilized  cells  are   attracted  to  the  injured  myocardium  after acute myocardial infarction   (Takahashi, Kalka et al. 1999)   (Orlic,  Kajstura et al. 2001) .   The i nh ibition of specific proteases  like cathepsin L  play s  a  critical  role  for   the  invasive  and  functional  capacity  of  EPC - mediated  neovascularisation in ischemic tissue  (Urbich, Heeschen et al. 2005) .   In patient s  with  ac ute  myocardial  infarction,  intracoronary  infusion  of  autologous  adult  progenitor  cell s  either from  the  bone - marrow or from  the  blood resulted in significant increase of  LV  (left ventricular)  ejection fraction, normalization of flow reserve and coronary wal l  motion  as  well  as  in  reduction  of  the  end  systolic  LV  volume  within  four  month   (Assmus, Schachinger et al. 2002) .  Based on this study, intracoronary administration   of  progenitor cells derived from  the  bone marrow ,  combined with optimal reperfusion  by stent therapy and medical treatment ,  improved the recovery of global and regional  left ventricular contractile recovery after myocardial infarction in a multicenter trail  (Schachinger, Erb s et al. 2006) .   Different drugs like AMD - 3100  (De Clercq 2005) ,  statins   (Vasa, Fichtlscherer et al. 2001) , EPO   (He eschen, Aicher et al. 2003)  and   estrogens   (Strehlow,  Werner  et  al.  2003)   interfere  with   the  number  of  circulating  EPC s , migration and adhesion capacity, as well as EPC mobilization and homing .  1. Introd uction     8     Besides pharmacological agents and molecules, physical exercise influences E PC  mobilization support s   vascular repair  (Sandri, Adams et al. 2005) .     1.5   EPC  function in  diseases   Endothelial  precursor  cells  are  correlated  with  some  cardiovascular  diseases.  Increased  c ardiovascular  risk  factors  in  patients  result  in  decreasing  number s   of  circulating  progenitor  cells  by  influencing  their  mobilization  from  the  bone - marrow  and enhancing EPC senescence  (Hil l, Zalos et al. 2003) .  In patients with diabetes  mellitus ,  EPC s  have impaired functions for  neovascularization, e.g.  in cell  to  cell and  cell  to  matrix adhesion, proliferation  and tubulization with endothelial cells  (Tepper,  Galiano et al. 2002) .   Kissel et al.  showed in their studies that patients with  coronary  artery disease (CAD)  are less able to mobilize progenitor cells into  the  blood , which   correlate s   with  functional  limitation  of  hematopoietic  progenitor  cells  in  the  bone  marrow  niche  and  impairment  of   MMP - 9  (matrix  metalloproteinase - 9)   (Kissel,  Lehmann et al. 2007) .   On the other hand , bone - marrow derived VEGF - responsive  cells  like  EPCs  play  a  crucial  role  in  tumor  angiogenesis  by  supporting  neovasculari z ation  (Lyden,  Hattori et al. 2001) .   Tumors as  a tissue with own growth  and independent development release  growth factors like VEGF and  chemokines  like  CCR2  and  CCR5  (a  subfamily  of  chemokine  receptors)  from  neovessels  for  chemokine - dependent attraction of EPC s   (Spring, Schuler et al. 2005) .  These new  strategies for healing, res toration and prevention in cardiovascular  diseases  could be  useful to find new therapeutic approaches  (Kawamoto and Losordo 2008) .         1.6   Caspases  and their function     Apoptosis  is  an  evolutionary  conserved  pro grammed  cell  death  which  is  highly  important in embryonic development ,  tissue formation  and the elimination of harmful  cells   (Lamkanfi, Declercq et al. 2002) .  This  form of controlled death i s dependent on  the activity of c aspases , a family of pro - apoptotic enzymes  (Thornberry 1998) .  These 1. Introd uction     9     cysteinyl  aspartate  proteinases  cleave  their  substrates  after   a  specific  aspartate  residue   (Thornberry and Lazebnik 1998) .  Dependent on the species d ifferent   types  of  c aspases  have  been  described  so  far.  In  mammalian,  14   caspas es   have  been  identified  ( 11  in human)   and  ten  in mouse,  seven  in  Drosophila me lanogaster  and  four in  Caenorhabditi s elegans   (Lamkanfi, Declercq et al. 2002) . The cell synthesizes  caspases as   precursors called zymogens   without or low catalytic activity. Caspases  are  divided  into  two  classes:  initiator s   and  effectors .   They  contain  an   N - terminal  prodomain like  the caspase recruiting domain (CARD) or the death effector domain  (DED) (Fig.1.6.1.).        Figure 1.6.1 :  Schematic illustration of the two caspase classes   Inactive proenzymes are composed of an amino - terminal  pro domain , a large subunit, a small  subunit and  linker region s  between them  with a n  aspartate residue as internal cleavage sites  for catalytic activation.  M odified  after   (Lavrik, Golks et al. 2005)   Initiator  caspases  like  caspase - 2,  - 8  and  - 9  are  autoactivated  under  apoptotic  conditions by  linking  the prodomain of the caspase to death signalling complexes,  also  called  “proximity - induced”  activation.   As  a  complex ,  c aspases  undergo  dimerization to form an active conformation as a heterotetramer containing two large  and  two  small  subunits   of   two  procaspases .  Investigated  multimeric  caspase  complexes are the apoptosome (caspase - 9 activation)   (Riedl and Salvesen 2007) ,  the  inflammasome  (cas pase - 1  activation),  the  piddosome  (activates  caspase - 2)   (Tinel and Tschopp 2004)  and the de ath - inducing signalling complex (called DISC , 1. Introd uction     10     which   activates  caspase - 8)   (Kischkel,  Hellbardt  et  al.  1995)   (Peter  and   Krammer  2003) .  They  are  further  classified  into  the  extrinsic  pathway  or  intrinsic  activation   (Fig.1.6.2.) .                             Figure  1.6. 2:   Schematic  illustration  of  the  main  extrinsic  and  intrinsic  apoptosis   induction pathway s   Two  alternative  pa thways  can  activate  the  apoptotic  induction.  The  extrinsic  pathway  is  controlled  by  death receptors  (e.g. Fas)  on the cell surface  and  is  binding of specific death  ligands like FasL  and the   intrinsic   pathway   by  mitochondria .  Both   pathways  lead to activatio n  of  an  initiator  caspase:  caspase - 8  for  the  extrinsic  pathway  and  caspase - 9  at  the  apoptosome for the intrinsic pathway.  Then, t he  initiator s  activate  downstream ( executioner )   caspases  resulting in  cleav ag e  of  the death substrates .   A positive feedback  cou ples  these  two pathways.  For example, cleavage of  proc aspase - 3  by caspase - 9  activates  in a  feedback  loop   caspase - 8  and even cleavage of more caspase - 3 . This entails  an amplification  of  the  apoptotic signal.   Illustration by   (Grutter 2000)     Key  effector  caspases  like  caspase - 3,  - 6  and  - 7  are  missing  the  prodomain.  Consequentially, they are not  cap able  of  autoactivation  and  are  dependent on the 1. Introd uction     11     cleavage  by   active initiator cysteine proteases like caspase - 2,  - 8 or  - 9 after  a specific  internal aspartate residue. Initiator caspases in  Drosophila m elanogaster  are D REDD  with a DED - prodomain like c aspase - 8  ( mammals )  and DRONC w ith a long amino - terminal CARD domain similar to casp a se - 2 or  - 9. DRICE, DCP - 1 and DECAY are  highly homologue to each other and are close relatives  of  the mammalian effector  caspase - 3  (Kumar and Doumanis 2000) .  On c e s  activated, effector caspases cleave  a wide variety of intracellular targets resulting in cell death.  Some caspase substrates  in the apoptotic way are  RO CK1  (Sebbagh, Renvoize et al. 2001) , R ac GTPases   (Zhang, Zhang et al. 2003) , myosin light chain kinase (MLCK)   (Petrache, Birukov et  al.  2003)   and  plectin   (Stegh,  Herrmann  et  al.  2000)   which  are  involved  in  cytoskeleton formation.         1.7   N on - apoptotic functions  of caspases   In th e last years,  several  publications  about the  non - apoptotic functions of caspases   have been published .  Loss - of - function in  Drosophila  DREDD,  a caspase  related to  caspase - 8, prevents bacterial infection   (Leulier, Rodriguez et al. 2000) .  In  Drosophila   spermatozoid differentiation, caspase - 3 - like effector ca spase  DRICE  is important for  elimination  of  the  cytoplasm  regulated  by  a  specific  cytochrome  c  resulting  in   functional sperm development   (Arama, Agapite et al. 2003) .   Further more , border cell  migration in Drosophila ovary was supported by Drosophila inhibitor of apoptosis 1  (DIAP1) whereas loss of the  a ccording gene caused  inhibition of  migration in this  Rac - dependent cell process  (Geisbrecht and Montell 2004) . Recently, caspase - 11   was shown to  trigger actin depolymerisation during inflammatory events  ( Li, Brieher  et al. 2007) .   Additionally , the executioner caspase - 3  targets  Nanog, a transcriptional  regulator,  by cleavage  and  thus   mediates  embryonic stem cell differentiation  (Fujita,  Crane et al. 2008)  as well as  influencing hematopoietic stem cell hom eostasis via  cytokine - influenced  signalling  (Janzen,  Fleming  et  al.  2008) .   Furthermore,   executioner  caspase s  are   necessary  for  lens  development   (caspase - 3)  (Zandy,  Lakhani et al. 2005) , erythroblast  (Zermati, Garrido et al. 2001) , platelet  (caspase - 3 1. Introd uction     12     and  - 9)  (De  Bo tton,  Sabri  et  al.  2002)   and  embryonic  keratinocyte  differentiation  (caspase - 3)  (Okuyama, Nguyen et al. 2004) .   1.8   Caspase - 8   Intracellular  c aspase - 8  activation  in  the  cell  death - inducing  pathway  by  the  TNF  (tumor necro sis factor) receptor family  triggers apoptosis  (Boldin, Goncharov et al.  1996) .  Investigation s   in  the last years revealed non - apoptotic functions of  c aspase - 8.  This  cysteine  protease  is  involved  in  embryonic  development,  monocyte  differentiation, T  cell  activation as wel l as T  and B cell proliferation . Wallach  and co - workers  investigated  the  importance  of  caspase - 8  for  apoptosis  by  generating  caspase - 8  deficient  mice   (Varfolomeev,  Schuchmann  et  al.  1998) .  H omozygous  deletion of  the   caspase - 8 gene s  lead s  to  embryonic  death around day E11.5 with an  abnormal phenotype.  Caspase - 8 deficiency  result ed  in increased erythrocytosis in  the liver, hyperaemia in many organs , e.g. in the brain and  in the  lens of the eye,  and  blood  vessels .  Furth er more ,  histological  investigation  showed  defects  in  the  heart   muscle and neural tube  development  as well as  a  reduction   in  th e hematopoietic  precursor  pool.  Ex  vivo   cultured  fibroblas t s  of   caspase - 8  deficient  embryos  were  resistant  to  death  induction  by  T NF  receptors,  Fas/Apo1  and  DR3   compared  to  heterozygous  littermates   (Varfolomeev,  Schuchmann  et  al.  1998) .   Caspase - 8 - deficiency constricted to the T - cell lineage in mice revealed  functional importance  of  this  cystei nyl  protease  in  T - cell  h omeostasis,  immun e   respons e   and  result ed   in  infiltration of T cells into organs like liver, lung and kidney  in   older mice   (Salmena,  Lemmers et al. 2003)   (Salmena and Hakem 2005) .  H umans with inherited genetic  deficiency in caspase - 8 sho w defects in T, B and NK (natural killer) cell activation   and autoimmunity   (Chun, Zheng et al. 2002) .  A dditionally,  the specific transcription  factor NF - ĸ B (Nuclear Fac tor κB ) activation is dependent on enzymatic activity of  caspase - 8  induced  by   bacterial  and  viral  antigens   like   Fc  receptors   or  Toll - like  receptor 4  but  is  independent of TNF (Tumor necrosis factor)   (S u, Bidere et al. 2005) .   Furthermore,  fetal liver  hematopoietic  stem cells  are not able to   proliferate  without  caspase - 8 enzymatic activity  (Pellegrini, Bath et al. 2005) .  Cell - restricted deletion of  caspase - 8 revea led  embryonic lethality only in  full knockout  mice  and  in  mice  with a 1. Introd uction     13     specific depletion of Caspa se - 8 in endothelial cells  (Varfolomeev, Schuchmann et al.  1998)   (Kang, Ben - Mos he et al. 2004) .   Deletion  of caspase - 8  in a tissue -  and time - specific  manner  by  different  promoters  like  Mx1,  LysM,  Lck  and  Alb  leads  to  functional deviation in the process of various cell types like hematopoietic precursor,  monocytes, T and B cells and l iver regeneration. Caspase - 8 knockout  mice  as well  as  de p letion  by  the  endothelium - specific  Tie1 promoter revealed strong evidence for   a   non - apoptotic  role  during embryogenesis evidenced by failed yolk sac vasculature   (Kang,  Ben - Moshe  et  al.  2004) .   In  the  context  of  therapeutical   approach ,   it  is  specifically interesting that    f ibroblast from caspase - 8 deficient  mice show decreased  cell motility and calpain functionality resulting in downregulation of Rac activity and   lamellipodial organisation  in tumor growth  (Helfer, Boswell et al. 2006) .         1.9   Integrins  and their function in  vasculogenesis and  angiogenesis   Differentiat ion  of   endothelial  pr ecursor  c ells   need  specific  molecules  for  adhesion  and migration  during vasculogenesis ,  sprouting  of  vessels  as well as  cell recruitment  in  angiogenesis   but  also  signal  receptors   for  proliferation,  survival  and  apoptosis .  Integrins  are  a  family  of  heterodi m eric  transmembrane  cell  surface  glycoprotein  adhesion   molecules .  They consist of  one out of 18  α  and  one out of 8   β  subunit, each  containing a large extracellular domain, one  α - helix crossing the cell membrane and  a  short  cytoplasmic  part.   Integrins  are  i nvolved  in  cell - cell  contact s ,  cell - matrix  adhesion  and  signal  transduction.  Mammal ian  cell s  express  a  large   variety  of   different  integrins  on their cell surface mostly with overlapping functions.  For fast cell  response, signal transduction across the memb rane takes place either in inside - out   (e.g.  intrinsic  regulatory  signals  from  cytoplasm  control  integrin  function  by  transmitting  signals )  or outside - in  (e.g. ligand binds to its receptor on the cell surface   and sends signals to the cytoplasm )  signaling  th rough integrins   (Qin, Vinogradova et  al. 2004) .   The extracellular domain is connected to  proteins of the extracellular matrix  like  fibronectin,  fibrinog en,  vitronectin ,   collagen ,  laminin,  osteopontin  and  thrombospondin   (table  1. 10 .1) .  The  short  cytoplasmic  domain  communicates  with  adaptor proteins like talin and paxillin connected to the cytoskeleton.  Many of the 1. Introd uction     14     subunits  of  heterodimers  have  a n   embryonic ally  lethal  knockout  phenotype.  The  heterodimer  α 5 β 1  is  extremely  important  in  angiogenesis.  Genetic  deficiency  in  integrin  α 5  results in  embryonic  lethality around day  E 10. Mice embryos suffer from  a  defect s   in  normal  development  of  the  yolk  sac  and  vessel  formation  resulting  in  vascular  morphogenesis .   Similar  effects  were  reported  of   fibronectin - deficient  embryos   (Francis,  Goh  et  al.  2002) .  Integrin  β 1  null  mice  have  an  even  worse   phenotype  than   α 5  K.O. mice . They die earlier without any vascular  network   (Fassler  and Meyer 1995) . Specific  integrin  β 1  K.O. in endothelial cells  induced  by the Tie - 2 - Cre system  revealed sprouting and branching defects  showing the importance  for   angiogenesis   (Tanjore, Zeisberg et al. 2008) .   Integrin  α 4   subunit  specific deletion in  endothelial  and  hematopoietic  cells  leads  to  mobilization  and  results  in  increased  fraction of  bone marrow - derived  circulating progenitor cells in the blood  (Priestley,  Ulyanova  et  al.   2007) .  Full  knockout  of  α 4  integrin  show s   failure  in  placentation,  cardiac vessel  growth  and  development of the  outer layer of the heart wall   (Yang,  Rayburn  et  al.  1995) .  The  absence  of  the  s ubunit  α v  as  part  of  the  vitronectin  receptor leads to 100%  mortality  with in the first day  after  birth   (Bader, Rayburn et al.  1998) .  Mice  suffer  from  defects  in  cell  interactions  and  cerebral  hemorrhage   (McCarty, Lacy - Hu lbert et al. 2005) . Interestingly, integrin  β 3 -  and  β 5 - null mice  are  born  with a  normal   vascular development  and  are  fertile but  have  some  defect s   in  placenta and platelet aggregation   (Hodivala - Dilke, McHugh et al. 1999) .  Surprisingly,   t hese integrins  show up regulation in sprouting  angiogenesis   (Max, Gerritsen et al.  1997) .   Because  of  the  angiogenic  involvement  of  integrins  in  cancer,  some  are  targeted in clinical trials.   1. Introd uction     15     Table:  1. 10 .1: Some integrins and  the  receptors                                       http://anatomy.iupui.edu/courses/histo_D502/D502f04/lecture.f04/cell.f04/cellf04.html   modified     1.10   Cbl - b, an E3 ubiquitin ligase   Ubiquitination  is  an  impor tant  physiological  process  in  mo dification,  regulation  of  expression  and recycling of damaged and redundant proteins . It is  managed by the  members of the  large  Ubiquitin - proteasome system  in  the  nucleus and cytoplasm .   Proteases of the E1, E2 and E3 family  are very important in the proteasome system.   Enzyme m embers of the E3 family  catalyse the conjugation of ubiquitin molecules  from E2 proteins to lysine residues of specific target molecules  (Fig.1.11.1)   resulting   in mono - , multi -  or polyubiquityl ation  (rev iewed in  (Ciechanover 2005) ) .                                     1. Introd uction     16     Figure 1.11.1: Ubiquitin - proteasome system   Three different types of enzymes are involved in the proteasomal pathway by tagging target  proteins with ubiquitin degradation.  www.med.upenn.edu/immun/PaulaM.OliverPhD.shtml   Polyubiquitylation mostly  leads to  protein degrad ation, whereas monoubiquitylation   is   involved in  intracellular  signalling  processes   (Hicke 2001) .  The Cbl family of  the  E3  ubiquitin  ligases  are  key  regulators  of  signal  transduction  of   many  cell   surface   r eceptors  consequently  regulate   development  and  cell  functions.  Due  to   their  discovery in retrovirus es   they are also  known  C asitas  B - l ineage  (Cbl)  lymphoma . In  mammal s , three homologues  Cbl proteins have been  identified  so far: c - Cbl, Cbl - b  and  Cbl - c.  Cbl  p roteins  consist  of  a  conserved  N - terminal  tyrosine - kinase - binding  domain, a ring finger motif, a proline rich  part and a C - terminal ubiquitin - associated  domain with a leucine zipper motif  which is missing in Cbl - c  (Fig.1.11.2) .        Figure 1.11.2: Cbl prote in structure   Domain  structure  of  c - Cbl,  Cbl - b  and  Cbl - 3  ( ≡ Cbl - c)  ( modified  after   (Thien  and  Langdon  2005) ) .   c - Cbl and Cbl - b  are adaptor proteins and  play an important role in T cell immunity  reflected  in  the  phenotype  of  knockout  mice   (Bachmaier,  Krawczyk  et  al.  2000)   (Naramura, Jang et al. 2002) .  T cells are a subtype of t he white blood cells, coming  from the bone marrow and mo v ing to the thymus for  maturation .  The process of  T  cells  which  present T cell receptor s  on their cell surface for recognizing antigens from   non - self origin   is  called autoimmunity . Knockout of  these  t wo E3 enzymes leads to  hypersensitivity of the T cell receptor  tolerance  and enhanced downstream signalling 1. Introd uction     17     independent  of  CD28   (Bachmaier, Krawczyk et al. 2000)   (Chiang, Kole  et al. 2000) .  Further more , Cbl - b is postulated  to be  a negative regulator  of  receptor clustering as  well as raft aggregation  (Krawczyk, Bachmaier et al. 2000) .  Cbl - b plays also a role  in  autoimmune diseases such a s arthritis and diabetes  (Yokoi, Komeda et al. 2002) .  Integrin - mediated  cell  signalling   and  adhesion   by  Rap1  activation  is  negatively  regulated by  Cbl - b  (Shao, Elly et al. 2003) .  Cbl - b - deficient mice  have an  increase d   peripheral lymphocyte activation , organ infiltration by T and B lymphocytes  and T cell  proliferation  with  spontaneous  autoimm unity  (Bachmaier,  Krawczyk  et  al.  2000)   (Chiang, Kole et al. 2000) .   Moreover,  c - Cbl and Cbl - b  have  regulatory ef fects in other  cell lines.  E3 enzymes, for example, control ex pression  of   stem cell factor receptor  in  mast cells  (Zeng, Xu et al. 2005) .   S tem cell factor receptor belong s to the receptor  tyrosine kina se s  (RTK)  and is  expressed on mast cells, hematopoietic stem cells and  interstitial  cells.   Moreover ,  Cbl - b - / -   mast  cells  produce  higher  levels  of  different  cytokines like IL - 6, TNF α  and MCP - 1  (Gustin, Thien et al. 2006)  and filtrate into white  adipose tissue  (Hirasaka, Kohno et al. 2 007) .      1. Introd uction     1     1.11   Aim of this study   Endothelial  precursor  cells  are  required  during  embryonic  and  adult  neovascularization.  Previous studies already demonstrated that  EPCs  can be  used  for  therapeutic  enhancement  of   vascular  repair  in  clinical  tr i a ls.   The  vasculog enic  potential of progenitor cells depends on an appropriate retention of the infused cells  in   the  ischemic  tissue.  However,  cell - autonomous  mechanisms  regulating  the  vascularisation  by  progenitor  cells  are  not  well  understood.  Beyond  cell  death  signals, c aspase enzymes regulate cell morphology and migration in many cell types.  The isoform caspase - 8 is involved in differentiation and proliferation and  is  essential  for embryonic vasculogenesis in C aspa se - 8 deficient mice.    In this study,  we first investigate d the role of caspase inhibition for EPC survival and  retention.  These results turned our focus  on caspase - 8 as a critical protease for EPC  function and maturation . In  closer  detail, we investigated the  targets  of caspase - 8   involved in cell adhesion and mi gration   Besides surface molecules like integrins  and CXCR4 , we point ed  our interest to the   negative  regulator of cell adhesion, Cbl - b ,   in vitro  and  in vivo .    2. Materials and Methods     2     2.   Materials and Methods   2.1   Cell s   The cells used in the different experiments are listed below ( Table   2.1 . 1 ).     Table  2.1 . 1 :  Cells and their origin   Human/mouse cell s   comment   EPC   Endothelial progenitor cells isolated from  human  peripher al   blood  from  mixed  donors    HUVEC   Pooled human umbilical vein endothelial  cells (from Cambrex)   HMVEC   Human microvascular endothelial cells   HEK293   Human embryonic kidney epithelial cells  (transformed cell line  from Cambrex )   Mouse BMC   Bone  marrow  cells  isolated  from  hind  limbs  of mice   Mo use  sple en  EPC   Endothelial progenitor cells isolated from  spleen  with  Ficoll  density  gradient  (protocol like EPC from peripher al  blood)     2.2   Cell culture of HUVEC, HMVEC and HEK293 T   HUVEC   and  HMVEC   were  grown   in  culture  medium   in  flasks  (Greiner)  at  37°C,  5%   CO 2   and  95%  air  humidity  until  the  third  passage.  For  passaging,  cells  were  washed with phosphate buffer (PBS, Gibco) and trypsinate d  with 3   m l  trypsin/EDTA 2. Materials and Methods     3     ( Boehringer) until cells  are  almost detach ed .  10   m l  EBM was used to stop enzyme  reaction and resusp ending the cells. For cell culture maintenance cells were seeded  again in 250   m l  flasks.  For  ex vivo  experiments cell number was  defined  and  cells  were  see ded  with  a  density  of  3.5 - 4.5   x   10 5   cells  per  6   cm  culture  dishes.  After  18 - 20   h of cultivation  cells  were used for experiments.    HEK293 T   cells  were  cultured  in  DMEM  medium  and  passaged  like  HUVECs.  Passages between two and three (HUVEC , HMVEC )  and  eight  to  fourteen (HEK293)  were used for  ex vivo  experiments. The cell lines with the specific medium are li sted  below ( Table 2.2.1 ).     Table  2.2 . 1 :  Cells and their specific medium   Cell  type   Culture medium   Supplementary agents   EPC   Endothelial cell basal  medium (EBM) from  Lonza   20% fetal calf serum (FCS) (Boehringer) ;   hEGF (10µg/mL), Hydrocortisone (1µg/mL),  bovine brain extract (3µg/mL), Gentamycin   Sulfat (50µg/mL), Amphotericin - B (50mg/mL)  ( = single quots Lonza )   HUVEC   Endothelial cell basal  medium (EBM) from  Lonza   10% fetal calf serum (FCS) (Boehringer) ;   hEGF (10µg /mL), Hydrocortisone (1µg/mL),  bovine brain extract (3µg/mL), Gentamycin  Sulfat (50µg/mL) , Amphotericin - B (50mg/mL)   ( = single quots Lonza )   HMVEC   Endothelial cell basal  medium - 2  (EBM - 2 )  from  Lonza   10% fetal calf serum (FCS) (Boehringer),  single quots (Lonz a)   HEK293   DMEM 4500 Glucose  with Glutamax (from  Gibco)   10% heat inactivated FCS,  Penicillin/Streptomycin (500U/mL) (Gibco)   Mouse  BMC   X - v ivo 10 (Cambrex)   2% FCS   Mouse  spleen  EPC   Endothelial cell basal  medium (EBM) from  Lonza   2 0% fetal calf serum (FCS) (B oehringer) ;   hEGF (10µg/mL), Hydrocortisone (1µg/mL),  bovine brain extract (3µg/mL), Gentamycin  Sulfat (50µg/mL) ( = single quots Lonza )  2. Materials and Methods     4     2.3   Isolation  and  ex  vivo   endothelial  differentiation  of  human  endothelial  progenitor cells (EPC)    Mononuclear cells (MNCs)  were isolated by Ficoll  (Biocoll density 1.077, Biochrom)  density gradient centrifugation  (800x   g, 20   min, RT, no brake)  from human peripheral  blood buffy coats. Immediately after isolation, 8x10 6   MNC/ml were plated on culture  dishes  or T - 75 culture flasks  (Greiner)   pre coated with fibronectin  (10   ng/ml in PBS,  Sigma) for 30   min  and maintained in  EBM complete (EBM + FCS + single quots)  medium   at 37°C, 5%   CO 2  and 95% air humidity.  After 3 days in culture, non - adherent  cells  were  removed  by  thorough  washing  wi th  PBS  and  adherent  cells  were  incubated in fresh  EBM complete  medium and  were used for following experiments  e.g.  with  caspase  inhibitors  (Sigma)  in  different  concentrations  or  cytokines  like  Interleukin - 6 (5 and 10   ng/ml, Peprotech). Afterwards, cells we re  stained with 1,1' – dioctadecyl - 3,3,3',3' - tetramethylindo carbo cyanine - labeled  acetylated   low - density  lipoprotein (Dil - Ac - LDL, 2.4 µg/m l ; Harbor Bio - Products) at 37°C for  1   h  and fixed   with  4%  Formaldehyde.  Further,  growth  factor  release  was  measured  by  ELISA  kits  (Quantikine,  R&D  System)  after  stimulation.   The  concentration  of  inhibitors  was  adapted to each of the experiments. For longer incubation times the zIETD dose was  decreased from 100   µM to 20   µM because the solvent DMSO showed some toxicity if  in cubated for prolonged time.     2.4   Isolation of EPCs from mouse spleen  -  EPC - assay    Spleens from mice were completely homogenised and carefully transfered on  Ficoll  (Biocoll  density  1.077,  Biochrom).  After  centrifugation  at  800x   g,  20   min,  RT,  no  brake, mononucl ear cells were collected and washed with PBS. After removing the  supernatant cells were resuspend in EBM complete. 4x10 6   cells were seeded into 24 - well plates precoated with 1:100 diluted fibronectin (Sigma). After four to seven days  at 37°C,  5%   CO 2  and 95 % air humidity cells were washed once with PBS and stained  with  1,1' – dioctadecyl - 3,3,3',3' - tetramethylindo carbo cyanine - labeled  acetylated   low - density  lipoprotein  (Dil - Ac - LDL)  for  1   h  at  37°C.  After  four   days  the  number  of 2. Materials and Methods     5     adherent EPC s  was counted with  a   fluorescence microscop e  in 20x   magnification (5  fields per view). To calculate the EPC   colonies  (one colony exists of 5 cells at least)   the cells were incubated in EBM  complete  for  three   more days. Cells  were  fixed in  2% formalin   solution and colonies wer e counted in 10x   magnification.     2.5   Gene knockdown by RNA interference (siRNA - mediated)   Small interfering RNA s  ( oligonucleotides) were used for specific mRNA suppression in transfectable cells  (   Table  2.5 . 1 ).  HUVECs  were  grown  to  60 - 7 0%  confluence  and  transfected  with  GeneTrans II (MoBiTec). The hydrated Gene Trans II reagent was diluted in 0%   EBM  (EBM  medium  without  FCS  and  single  quots  which  contains  growth  factors  and  antibiotics).  Specific  siRNA  or  scrambled  from  20   µM  stock  were  d iluted  in  DNA  dilutent B (also supplied by MoBiTec). Both reagents were mixed well by pipetting  several times and incubated at room temperature (RT) for 5   min. siRNA solution was  added to the diluted Gene Trans II reagent and was incubated for additional 5   min to  allow complex formation. In the meantime, HUVEC monolayers were washed two  times with 0%   EBM without antibiotics, FCS and supplements. 3   ml 0%   EBM were  added to the cells and the Gene Trans II/siRNA complexes were added dropwise.  HUVEC were incubat ed at  37°C, 5%   CO 2  and 95% air humidity for 4   h.  Then, EBM  medium with siRNA solution complex was removed and cells were washed with PBS.  Fresh  EBM  complete was  added to  the  cells.  Expression  of the  target  gene  was  analyzed after 24 and 48   h.     Table  2.5 . 1 :   Oligonucleotide sequences   siRNA (target gene)   sequence   Scramble   UCAAGAAGCCAAGGAUAAU   Cbl - b   CGGUUAAGUUGCACUCGAU    2. Materials and Methods     6     2.6   RNA isolation    The  TRIzol  reagent  (Invitrogen)  method  was  used  to  isolate  whole  mRNA  from  HUVE Cs and EPCs. Cells were washed  carefully  with PBS and directly lysed with an  appropriate volume of TRIzol reagent ( Table  2.6 . 1 ).      Table  2.6 . 1 :  Volumes of used Trizol and Chloroform f or defined number of cells   Number cell/tube   Volume   of TRIzol   Volume   of  c hloroform   1 x10 6 - 5 x10 6   1 ml   0.2 ml   1 x10 5 - 1 x10 6   0.8 ml   0.160 ml   ≤ 1 x10 6   0.4 ml   0.080 ml     The  cells  were  homogenised  in the  reagent  by  pipetting  until all  cell  components  were di ssolved. After 5   min of homogenisation at room temperature, chloroform was  added  as  indicated   ( Table  2.6 . 1 ).  After  shaking  the  tubes  for  15  seconds  and  incubation for additional 3   min, the suspension was centrifuged at 12.000x g,  4°C for  15   min. The colourless upper aqueous phase (containing RNA) was transfered in a  new tube. The approximate volume was defined, 0.8   times of isopropyl alcohol was  added  and  shaken  vigorously  by  hand.  After  10   min  of  incubation  at  room  temperature,  sa mples  were  centrifuged  at  14.000x   g,  4°C  for  15   min.  The  supernatant  was  well  removed  and  the  pellet  washed  with  75%  ethanol.  After  spinning  again  and  discarding  the  supernatant,  the  pellet  was  air - dried  for  10  minutes. Afterwards the RNA pellet was dissol ved in 15 - 20 µL RNAse - free H 2 0.     2.7     Oligonucleotide microarrays (Affymetrix, Inc.)   RNA from EPCs, HUVECs, mononuclear cells and CD34 +  cells were send to the  Affymetrix  Inc.  for  RNA  expression  analysis.  Ten  microgram  of  total  RNA  was  hybridized  to  the  HG - U95A v2  microarray  (Affymetrix,  Inc.).  The   standard  protocol 2. Materials and Methods     7     used for sample preparation and microarray processing is available from Affymetrix.   Expression data were analyzed using Microarray Suite version 5.0 (Affymetrix, Inc.)  and GeneSpring   version 4.2 (Sili con Genetics).     2.8   RT - PCR   RNA concentration was determined in UV - light at 260   nm. For RT - PCR 2   µg of RNA  were first reverse transcribed into  cDNA.  Afterwards, mRNA was reverse transcribed  by  M - MLV  Reverse  Transcriptase  (Invitrogen).  GAPDH  expression  was  used  as  loading  control.   For  semiquantitative  RT - PCR,  conventional  PCR  was  done   with  specific  primers  (Table  2.8.1  and  2.8.2)  against  the  target  genes   and  afterwards,  DNA was separated in agarose gel to visualise the amount of DNA.     Table  2.8 . 1 :  Human primer sequences   RT - PCR   5`  à 3` sense sequence   5`  à 3` antisense sequence   Human  Caspase - 8   CTGTGCCCAAATCAACAAGAGC   CTGTCCATCAGTGCCATAGATG   Human  Cbl - b   GGAGAAGACTTGGAAGCTCATG   CATGAAGGCACTGTCTGAATAC   GAPDH   TCACCATCTTCCAGGAGCGAGATC     GAGACCACCTGGTGCTCAGT GTAG                2. Materials and Methods     8     Table  2.8 .2 :  Murine primers for genotyping   RT - PCR  genotyping   Allele   5` à 3`sense  s equence   5` à 3`antisense  sequence   Caspase - 8  conditional  knockout mice   Wildtype,  knockout,  floxed  and  deleted allel   TAGCCTCTTTGGGGT TGTTCTACTG       De leted allel     GCGAACACGCCGTGTTT CAAGGGC     Wildtype,  knockout  and floxed allel     CGCGGTCGACTTATCAA GAGGTAGAAGAGCTGTA AC   Cbl - b  knockout  mice   Wildtype   CATCTCAGTGTTTGA ATTTG   GGAAAAATATTAGTTACA ACTGG     Deleted   ATGCCTGCTCTTTAC TGAAG   GGAAAAATATTAGTTACA ACTGG     2.9   Plasmid tr ansfection in HUVEC and HEK293 using Superfect (Qiagen)   HUVEC  and HEK293  were  transfected one day after seeding with 80% confluence.  First, 3   µg plasmid DNA and 18   µl Superfect were mixed in 150   µl 0%   EBM medium  by vortexing. During the 10   min of DNA - Super fect incubation, cells were washed with  0%   EBM medium. Then, 1.2   ml of EBM 10% with supplements was added to the  transfection mix. After removing the starving medium, the transfection solution was  equally added to the cells. After 3 h of incubation in an i ncubator (37°C, 5%   CO 2 ,  95% air humidity ), solution was removed and 3   ml of EBM 10% complete was added.  Cells were harvested after 48   h by lysis of the cells.        2. Materials and Methods     9     Table 2. 9 .1: Plasmids used in the experiments   Plasmid   V ector   Insert side   S election   Total size   Caspase - 8 (Flice)   pcDNA3.1( - )  (Invitrogen)   BamH I/ Hind III   Ampicillin    ~ 1440 bp    Cbl - b wt - HA   pCEFL   Hind III/ Kpn I   Ampicillin   ~ 2200 bp   Cbl - b N 1/2 - HA   pCEFL   Hind III/ BamH I   Ampicillin   ~ 1480 bp   Cbl - b N 1/3 - HA   pCEFL   Hind III/ BamH I   Ampicillin   ~ 1047  bp   Cbl - b C 2/3 - HA   pCEFL   Hind III/ Kpn I   Ampicillin   ~ 1833 bp     2.10   Lentivirus - transduction in HUVEC and EPC   HUVECs and EPCs were seeded in 12 - well plates to 80% density ( 1x10 5   cells /well).  The Multiplic ity o f Infection (MOI) is the number of vector units use d to transduce a  single cell.  T he  used  MOI is  five;   consequently  the number of vector transducing  units per cell is  5 .  The vector units provided by Sigma - Aldrich for caspase - 8 differ  between  1x10 7   and  1x10 8   transducing  units  (TU)  per  milliliter.  Each  well  was  transduced with 5x10 5  lentiviral particles supported by polybrene (8   µg/ml), a cationic  polymer which increases the efficiency of shRNA uptake into the cells. RNA isolation  was  done  with  the  RNAeasy  micro  kit  (Qiagen), followed  by  reverse  transcription   PCR.     2.11   Protein isolation  from whole cells   For protein isolation cells were washed with ice   cold PBS and lysed in lysis buffer  ( 20   mmol /l  Tris  [pH   7.4],  150   mmol/l  NaCl,  1   mmol/l  EDTA,  1   mmol/l   EGTA,  1%   Triton, 2.5   mmol/ l sodium pyrophosphate, 1   mmol/ l ß - gl ycerophosphate, 1   mmol/ l   Na 3 VO 4 ,  1   µg/m l  leupeptin,  and  1   mmol/ l   phenylmethylsulfonyl  fluoride)  containing 2. Materials and Methods     10     protease  inhibitor s   (Roche )  for  20   min  on  ice.  Insoluble  cell  components  were  separated from the cell lysate by centrifugation for 15   min at 20000x   g  (4°C). Protein  concentration was measured with Bradford Reagent.     2.12   Immunoprecipitation   After  Cbl - b  protein  overexpression,  cells  were  lysed  in  buffer  (for  procedure  see  above 2.11.). For preclearing the samples (500   µg), they were incubated with protein  A/ G  Plus - Agarose  (Santa  Cruz)  for  30   min  at  4°C  followed  by  cold  high  speed  centrifugation. Then, the specific antibody (anti - HA tag: Roche) was added to the  supernatant with rotation at 4°C over night. Subsequently, 20   µl protein A/G Plus - Agarose was added  for 1   h at 4°C. Finally, lysates were washed carefully with lysis  buffer. Immunoprecipitated Cbl - b was incubated with 2   units of recombinant caspase - 8 (Chemicon). At the end, the precipitates were mixed with loading dye and were  boiled for 5   min before the  cell proteins were separated in gel electrophoresis.     2.13   Colorimetric analyses of protein concentration according to Bradford   For protein concentration analysis 1   µl protein lysate was mixed into 799   µl H 2 O and  200   µl  Bradford  reagent  and  incubated  for  5   min   at  room  temperature.  The  absorption of protein was measured in a spectral photometer at 596   nm against a  reference.  Protein  concentration  was  calculated  on  the  basis  of  a  bovine  serum  albumin standard curve.     2.14   SDS - polyacrylamid gel electrophoresis (SDS - PAG E)   To  separate  proteins,  4x  loading  buffer  (250   mM  Tris/HCl  ph  6.8,  8%  SDS,  40%   Glycerin, 0.04% Bromphenolblau, 200   mM DTT) was added to a defined protein  amount. The solution was boiled for 5   min at 100°C to denature proteins. To  separate  proteins  according to their electrophoretic mobility ,   protein homogenisates were used 2. Materials and Methods     11     in a  discontinuous   sodium dodecylsulfate polyacrylamide gel electrophoresis  (SDS - Page)  after  Laemmli.  First,  the  protein  s olution  was  filled  in  the  stacking  gel  (0.5   M   Tris/HCl, pH 6.8; 0.4%   SDS) to concentrate the protein. The resolving gel is a  small pore size polyacrylamide gel ranging between 7  –  15% (0.5   M Tris/HCl, pH 6.8;  0.4%   SDS) depending on the expected protein siz e. Separation was done with 80 V  in the stacking gel and 120   V in the resolving gel using running buffer (0.25   M Tris,  1.92   M Glycin and 1%   SDS) in the Mini Protean electrophoretic system (BIO - RAD).  Molecular  weight  was  detected  by  a  standard  protein  marke r  (rainbow  marker,  Amersham).     2.15   Wet - blot method for specific protein detection (Western blot)   The Western blot method  (also called immunoblot)  is used to transfer proteins from  the  resolving  gel  onto  polyvinylidenfluorid  ( PVDF)  membranes  (Millipore)   by  an  e lectric field. First the PVDF membrane was activated  in  methanol for 1 minute and  then rinsed in H 2 O for 2 min . Then, 2 sponge pads and 6 papers of whatman were  preincubated  in  1x   wet  blot  buffer  (0.05   M  Tris,  0.038   M  Glycin,  0.1%  SDS,  20%   Methanol). A spo nge pad, Whatman paper (3   x), nitrocellulose membrane, gel,  again Whatman and sponge pad were built - up to a stack without air bubbles. The  stack was put vertically in a wet blot chamber (BIO - RAD) filled with 1x wet blot buffer.  The transfer ran at 20 W for  1.5 - 2   hours at 4°C. Transfered proteins were detected in  an  antibody - enzyme  reaction.   The  PVDF  membrane  was  probed  with  specific  antibodies  to  detect  the  target  protein.  First,  the  membrane  was  blocked  with  TBS/Tween  (50  mM  Tris/HCl,  ph  8,  150   mM  NaCl,  2. 5   mM  KCl,  0.1%   Tween - 20)  containing 3%  non - fat dry milk  (Töpfer)  or  3%   bovine serum albumin (Merck) for 1   h  gently shaking (Rotator, IKA - Labortechnik). Blocking the membrane is necessary to  prevent  non - specific  binding  of  the  antibody  to  the  membrane.  Subs equently,  the  specific target antibody in a tested dilution was added to the membrane for 2   h at RT  or over night at 4°C. After washing the membrane 3x with TBS - T,  a  species - specific  (e.g.  anti - mouse, anti - goat  or anti - rabbit)   horseradish  peroxidase - linked  secondary  antibody  was  used in conjunction with a chemiluminescent agent . After washing the 2. Materials and Methods     12     membrane  again  3x  with  TBS - T,  the  PVDF  membrane  was  incubated  with  a  substrate (Amersham ) which luminesces when exposed to the  conjugated enzyme   on the secondary antibody . For detection of the signal, x - ray films (Hyperfilm - ECL,  Amersham) were exposed to the membrane for various time points. The following  table contains the  used antibodies for Western Blot analysis (Table 2.1 5 .1).     Table 2.15. 1 :  Western Blot antibodies   First Antibody  (target protein)   Dilution   Blocking   Company   Second ary   antibody   Caspase - 8   1:1000   5% milk   Immunotech   Anti - mouse - HRP   Cbl - b   1:1000   3% BSA   Santa Cruz   Anti - rabbit - HRP   Integrin alpha5   1:500   3% BSA   Chemicon   Anti - rabbit - HRP   Integrin beta1   1:2500   3% BSA   Chemicon   Anti - mouse - HRP   Anti - ERK 1/2   1:1000   3% BSA   Cell Signaling   Anti - rabbit - HRP   Anti - HA   1:500   3% BSA   Roche   Anti - mouse - H RP     2.16   Adhesion assays   Ninety - six - well plates were  coated overnight at 4°C with 5   µg/ml  human fibronectin  (Roche) ,  ICAM - 1  or  Collagen  I   in  coating  buffer  (150   mM  NaCl,  20   mM Tris  HCl,  2   mM MgCl 2 , pH   9.0) and then blocked for one hour at room temperature with  3%  (w/v)  Polyvinylpyrrolidone  (PVP)  in  PBS.  Ex  vivo   expanded  human  EPC s   were  incubated  for  40   min  at  37 ° C  in  the  presence  of  zIETD  (100   µM)   and  afterwards  stained  with  2',7' - bis - (2 - carboxyethyl) - 5 - (and - 6) - carboxyfluorescein  acetoxymethyl  ester (BCECF - AM) .  A fter detachment with trypsin  all  cells were resuspend ed  in RPMI 2. Materials and Methods     13     1640 with 0.05% BSA.  Subsequently , EPC s were counted and 1.0x 10 5   cells/100   µL  were seeded  in to  fibronectin coated wells for  40   min at 37°C.  A dherent EPC were  quantified  in  triplicates  with  a   fluorescence  plate  reader  (Fluostat,  BMG  Lab  Tec hnologies) by washing  of non - adhering cells with RPMI 1640  in several steps.  The input was calculated with the plate reader before the first wash.     2.17   EPC  and HUVEC  migration assay   To determine the migration ca pacity of progenitor cells or transfected HUVECs,  ex  vivo   expanded  and for  6   h  with  zIETD   preincubated human EPC s   or HUVECs  were  resuspended   in  serum - free  RPMI  1640  (Gibco )  containing  0.05%  BSA  (Sigma,  Germany).  AT the previous day t ran swell membranes with  5   µm pore size (Costar )  were  coated  on  both  sides  wit h  fibronectin  (2.5   µg/mL;  Roche )  overnight  at  4°C.  Then, EPC (1 . 5 x10 5   cells/well)  or HUVECs (0.5x10 5   cells/well)  were incubated in the  upper  chamber  at  37°C  in  5%  CO 2   and  allowed  to  migrate  for  16  to  18   h   (5   h  HUVECs)   toward  the  lower  chamber  in  the  presence  or  absence  of  100   ng/mL  h uman SDF1α (Peprotech ). Cells remaining on the  upper surface of the transwell   membranes were mechanically removed and cells that had migrated to the lower  surface were fixed  with 4% formaldehyde. For quantification cell nuclei were stained  with  4`,6 - diamidinophenylidole ( DAPI ) .  M igrating  cells on the bottom of the  chamber  were  counted  in  5  random  microscopic  fields  using  a  fluorescence  micro scope  (Axiovert 100, Carl Zeiss ).     2.18   “ Scratch wound” assay   Pooled human umbilical vein endothelial cells (HUVEC) were cultured until the third  passage.  After  detachment  with  trypsin,  3.5x10 5   cells  were  grown  in  6   cm   culture  dishes for at least 20   h. Afterwards cells were stimulated with  100   µM  inhibitors  (e.g.  zIETD, zDQMD, zVAD) for 16   h.  T he next day, the cell monolayer was scraped with  a   sterile cell scraper to create a cell - free zone (width 14   mm). Cells were washed with 2. Materials and Methods     14     medium and  treated with inhibitors  again  as indicated for additional 2 4   h. Endothelial - cell migration was quantified by measuring the width of the cell - free zone (distance  between the edges of the injured monolayer) at  the time of injury and after 24   h of  cultivation using a computer - assisted microscope (Zeiss) at 5 distinct  positions (every  5   mm).                           Figure  2.18 . 1 :  Schematic illustration of the scratch wound experiments.       2.19   Spheroid assay   In this  three dimensional assay, cells are characterized by their sprouti ng ability in a  methocoel - collagen  gel.  Transfected  HUVECs  were  detached  by  adding  Trypsin/EDTA. EBM medium with 10% FCS and supplements was used to stop the  reaction. After pelletization, 48.000 cells were suspended in 12   ml EBM (10% FCS  and supplements)  –  methocoel - mix (80 to 20%). With a multistepper device, 100   µl  from this cell suspension was transfered into the cavity of a 96 - well plate with U - bottoms. After 24   h in the incubator, round spheroids were harvested and overlaid  with 80% methocoel/ 20% FCS  solution mix. After adding a collagen solution (pH 7.4)  and carefully mixing both solutions, the spheroid - collagen mix was transfered into the  cavity of 24 - well plate. After polymerization of the collagen gel at 37°C for 30   min,  100   µl of culture medium w ere added on top of the gel.   After 24   h of incubation at  37°C and 5% CO 2  s prouted spheroids were fixed with 10% formaldehyde.    2. Materials and Methods     15     2.20   Detection of proteins in whole cells by fluorescence microscopy   After  three  days  of  isolation,  attached  EPCs  were  cleared  by  wash ing  from  non - attached cells. Cells were stimulated with caspase - 8 inhibitor for the indicated period  of time in cell culture medium. After carefully removing any solution, cells were fixed  and  treated  with  saponine  for  permeabilization.  Staining  with  speci fic  antibodies  (caspase - 8, von - Willebrand factor, integrin  α 5, anti - nuc) and DNA (TOPRO, DAPI)  markers was followed by fluorescence microscopy.     2.21   Fluorescence  activated  cell  sorting  (FACS)  of  EPCs  and  mice  bone  marrow cells   Cells were  harvested with EDTA or  directly isolated from hind limb bone of mice and  were  incubated  with  specific  antibodies  (Table  2.19.1)  for  30  min  at  4°C  or  RT  followed  by  4%  formaldehyde  fixation.  Finally,  i mmunofluorescence  labeled  cells  were analyzed by quantitative flow cytometry u sing  FACS CantoII  (Becton Dickinson)  and  Diva Software.                    2. Materials and Methods     16     Table 2.21.1: Specific antibodies for human and mouse species   Antibody   Company   S pecies   CD117 ( c - Kit )   BD   mouse   CD11a,b,c   BD   human   CD18   BD   human   CD184 ( CXCR4 )   BD   mouse   CD184 ( CXCR4 )   BD   hum an   CD29 (integrin b1)   BD   human   CD 49d  (integrin alpha4)   BD   mouse   CD49e (integrin alpha5)   Immunotech   human   CD49e (integrin alpha5)   R&D Systems    mouse   CD45   BD   human   KDR  (Flk - 1, VEGF - R2)   BD   mouse   KDR  (Flk - 1, VEGF - R2)   R&D Systems   human   Lectin   Abcam   huma n   Sca1   eB ioscience   mouse   vWF   Abcam   human       2.22   Apoptotic  measurement  of  endothelial  precursor  cells  with  Annexin  V  (BD Pharmingen)   EPCs were starved with 0% EBM and stimulated with 50   ng/ml TNF α  (Sigma). Cells  which undergo apoptosis expose phosphatidyl serine from the inner membrane to the  outside of the cell surface. Suspension cells or adherent cells (detached by trypsin)  were  washed twice  with the supplied binding buffer. After cold centrifu gation, cell 2. Materials and Methods     17     pellets  were  resuspended  in  50   µl  binding  buffer.  FITC - annexin  V  antibody  was  added  and  the  cells  were  incubated  for  15   min  in  the  dark  at  room  temperature.  Annexin  V  specifically  binds  to  negatively  charged  phospholipids  like  the  phosphatidyl  serine  in the plasma membrane. Afterwards, percentage of apoptotic  cells was detected by fluorescence activated cell sorting (FACS).      2.23   Caspase activity analysis   Caspase activity was detected under normal cell culture conditions or after specific  inhibitor  treatment with apoptotic pushing reagents. Under normal conditions, cells  were washed once with cold PBS and protein extract was produced using provided  lysis  buffer  (Kit  Caspase - 3 - Chemicon,  Kit  Caspase - 8 - Sigma - Aldrich).  After  measurement of protein conce ntration, 100   µg were used in the colorimetric assay  kit.  Cell  lysates  were  incubated  together  with  Acetyl - Ile - Glu - Thr - Asp - p - Nitroaniline  (Ac - IETD - pNA) or  A cetyl - Asp - Glu - Val - Asp - p - nitroanilin e  (Ac - DEVD - pNA) as caspase  substrates for 3   h to detect hydrolysi s activity of caspase - 8 and  - 3. Detection of the  absorption the released chromophore p - Nitroaniline moiety was done by a microplate  reader at 405   nm.   For caspase - 8 specificity, cells were washed with PBS and incubated for 5   h with  EBM 0% without supplement s and two hours with TNF α  (50   ng/ml) to induce stronger  caspase - 8 activity. Further steps were done like in the protocol for normal treatment.     2.24   Murine ischemic hind limb model and BMC transplantation    The effect of injected mouse BMC s  or human  ex vivo  expanded EPC s  on ischemia - in duced  neovascularization  was  investigated  in  a  murine  model  of  hind  limb  ischemia.  1 x 10 6   bone  marrow  mononuclear  cells  or  EPC s   were  transplanted  intravenously in the tail of  mice one day after causing hind limb ischemia.  Two weeks  later, the morphology of  the limb was determined ( toe  necrosis rate) and  the  blood  flow ratio  of the ischemic to the normal leg  was measured  using  a laser Doppler 2. Materials and Methods     18     blood flow meter (Laser Doppler Perfusion Imager System, moorLDI - Mark 2). The  perfusion  of  the  ischemic  and  non - ischem ic  limb  was  calculated  on  the  basis  of  colored  histogram  pixels.  To  minimize  variables  including  ambient  light  and  temperature and to maintain a constant body temperature, mice were exposed to  infrared light for 10   min before laser Doppler scans. During th e scan, mice were lying  with their back on a heating pad   with their legs stretched and fixed. The calculated  perfusion  was  expressed  as  the  ratio  of  ischemic  to  non - ischemic  hind  limb  perfusion.      2.25   Immunohistochemistry   For  morphological  analysis,  10   µm  froz en  sections  of  the  adductor  and  semi  membranous  muscles  were  used.  Frozen  sections  were  thawed  for  30   min  and  incu bated  in  ice - cold  acetone  for  2   min.  Myocyte  membranes  were  stained  using  anti - laminin  (Abcam)  followed  by  anti - rabbit - Ig  Alexa  Fluor  488   or  6 47   (Molecular  Probes) and anti - CD31 (BD). After washing 3 x with PBS  sections were capped with  glass cover  slides .   For detecting incorporation of human EPC s  into hind limb ischemic tissue, frozen  sections  were thawed for 30   min at RT and fixed with 4%   PFA f or 10   min followed by  permeabilization with 0.2%   Saponin/PBS for 15 minutes. Mouse tissue was blocked  with  2%   mouse  serum  for  1   h  at  RT.  Sections  were  washed  with  PBS/2%   NaCl/0.05%   Tween20  and  stained  against  human - nuclei - antigen  ( 1:100;  Chemicon)  for 60   m in in blocking solution followed by mounting with DAPI medium.     2.26   Matrigel plug assay   For analysis of vascularization capacity of EPC s   in vivo ,  we subcutaneously injected  500   µl of growth factor reduced  matrigel (BD Bioscience) with 3   µl Heparin - Sodium  25000   (Ratiopharm)   on  the  back  of  nude  mice.   1x10 6   e x  vivo   expanded  and  pretreated cells were  transplanted  intravenously in the tail  of the  mice.  Aft er 7   days 2. Materials and Methods     19     the  matrigel  plugs  were   harvested  for  hemoglobin  concentration  measurements.  Plugs  were  homogenized  an d  matrigel  lysates  were  used  in  the  Drabkin  assay  (Sigma - Aldrich)  Stock  solutions  of  h emoglobin  were   used  to  generate  a  standard  curve. Results are expressed relative to total protein in the supernatant.     Alternatively,  the  matrigel  plugs  were   harvested  a f ter  7   days  and  embedded  into  paraffin. Sections were stained using a Cy3 - labeled mouse monoclonal antibody for  smooth  muscle  actin  positive  cells  (Sigma)  as  well  as  Isolectin  B4  (Vector)  and  scanned with  a  confocal  microscop e .        2.27   Statistical analysis   The r ecord data are expressed as mean  ±  SEM. Comparisons between groups were  analyzed by t - test or ANOVA (post hoc test: LSD= least significant difference) for  experiments with more than two subgroups (SPSS software). P values <0.05 were  considered  as  statistic ally  significant.  Numbers  of  independently  performed  experiments are mentioned at n.     3. Results     20     3.   Results   3.1   Caspases in endothelial precursor cells   Human  peripheral blood mononuclear cells were  isolated by ficoll density gradient  centrifugation  and  incubated under end othelial differentiation conditions  (endothelial  basal medium (Lonza) with 20% FCS and single quots (Lonza) containing endothelial  growth  factors,  bovine  brain  extract,  hydrocortisone,  gentamycin  sulfat  and   a mphotericin - B )   ex vivo  to generate endothelial  precursor  cells (EPC). These  ex vivo   cultured  pro - angiogenic  EPC s   express  endothelial  markers  such as  eNOS  (Vasa,  Fichtlscherer  et  al.  2001) ,  KDR  (VEGF - R2),  C D31,  CD105,  vWF ,  VE - cadherin  (Dimmeler, Aicher et al. 2001)   (Urbich, Heeschen et al. 2005)  and  the my eloid and  hematopoietic  markers  CD11   (Chavakis,  Aicher  e t  al.  2005)   and  CD45   (Urbich,  Heeschen et al. 2003) . Various cell surface markers are tested and are summarized  in  FACS  analysis  with  the  percental  ind ication  of  expression  on  adherent  EPC  (Fig.3.1.1).  3. Results     21                                 Figure 3.1.1: Cell surface expression of different marker on endothelial precursor cells   EPCs were tested for the cell surface expression of CD45, vWF, KDR , Lectin and CXCR4 by  FACS analysis. Unstained cells were used as control. Almost all cells express lectin and  CD45. More than the half of the measured cells expresses KDR, CXCR4 and vWF.  The  numbers indicate the percentage of total cells expressing the i ndicated markers.   Caspases have been originally described to be pro - apoptotic enzymes. Therefore,  their inhibition may comprise a novel therapeutic strategy to improve cell survival of  injected  cells  in  ischemic  tissues.  However,  unexpectedly  a ddition  of  t he  broad - caspase inhibitor zVAD or the  c aspase - 8 inhibitor zIETD during  ex vivo  cult ivation   unexpectedly  abrogated   the formation of fibronectin - adherent cells with endothelial  cell  characteristics   (Fig.3.1.2a).  Furthermore,  t he  inhibitor  zAEVD,  which  prefe rentially  inhibits  c aspase - 10,  led  to  a  partial  inhibition  of  EPC  formation,  whereas the  caspase - 3 and  - 6  selective  inhibitor zDQMD had no effect on EPCs. 3. Results     22     The  addition  of  the  c aspase - 8  inhibitor  zIETD  to  adherent  EPC s   growing  on  fibronectin during later st ages  (72 hours after isolation)  of  ex vivo  cult ivation  caused a  dose - dependent decrease in the number of adherent EPC s  ( Fig.3.1.2b ).            Figure  3.1.2:  Effect  of  various  selective  caspase  inhibitors  on  EPC  formation  and  adherence    Mononuclear cells were  isolated from human peripheral blood and cultured for 72 hours in  the presence of different caspase inhibitors as indicated on the x - axis (100   µM). Formation of  adherent precursor cells (a) was counted with a microscope after staining the cells with Dil - Ac - LDL  and  vWF.  *  p<0.0001  (b)The  detection  of  the  dose - dependent  detachment  of  adherent precursor cells (72 hours of culturing and medium change) after incubation with  zIETD for 6 hours was performed in the same way. * p<0.01; both experiments n=4, (mean ±  SEM)     3.2   Caspase - 8 expression in human cells   Having  shown  the  strong  effect  of  the  broad - caspase   inhibitor  zVAD  and  the  caspase - 8 inhibitor on endothelial precursor cell formation, we analyzed Caspase - 8  expression by western blotting in EPCs (Fig.3.2.1a, uppe r panel) and RT - PCR using  specific  primers  in  HUVEC,  human  peripheral  blood  mononuclear  cells  and  endothelial precursor cells (Fig.3.2.1a, lower panel). Additional microscopic images  revealed  caspase - 8  expression  in  the  nucleus  as  well  as  in  the  cytoplasm 3. Results     23     (Fig.3.2.1b). mRNA expression profiling indicates that caspase - 8 is highly expressed  in human CD34 +  cells, monocytes and fibronectin - adherent early EPCs compared to  low expression in human umbilical vein endothelial cells (HUVEC) (Fig.3.2.1c).     Figure 3.2 .1: Caspase - 8 detection in endothelial precursor cells    (a) Western Blot analysis to confirm protein expression in endothelial precursor cells and  ERK 1/2 as loading control (upper panel). Semiquantitative RT - PCR was performed using  RNA from HUVECs, human  peripheral blood mononuclear cells (freshly isolated as well as  cells grown in suspension for 72 hours) and outgrown (d3) endothelial precursor cells (lower  panel).  (b)  Fluorescence  images  of  outgrown  EPCs  by  staining  with  antibodies  against  caspase - 8,  vWF   (as  endothelial  marker)  and  TOPRO  (dye  for  nuclear  staining).  (c)  In  a  microarray, the mRNA expression level of caspase - 8 was significantly higher in CD34 +  cells,  monocytes (Mono) and endothelial precursor cells compared to HUVEC. * p<0.05 (mean ±  SEM)     3.3   C aspase - 8 activity is required for pro - angiogenic cell function  ex vivo   In  order  to  assess  the  effect  of  c aspase - 8  on  functional  abilities  of  EPCs,  we  performed adhesion and migration assays. After preincubation with zIETD or zDQMD  for 4   h,  ex vivo  cultured  EPC s   were tested for the capacity to adhere to different  matrices. Preincubation with zIETD but not zDQMD impaired the adhesion of EPCs   to  the  major  α5β1 - integrin  ligand  fibronectin  as  well  as  to  the  β 2 - integrin  ligand  ICAM - 1 and Collagen I matrices (Fig.3.3.1).     3. Results     24                                                                       Figure 3.3.1: Adhesion capacity of EPCs subjected to caspase - 8  inhibition   Endothelial  precursor  cells  adhere  to  fibronectin,  ICAM - 1  and  Collagen  I  following  preincubation of the cells with zDQMD but not with zIETD (100   µM) for 4 hours. * p<0.001;  n=3   Likewise in migration studies, zIETD pretreated EPC s  were significan tly inhibited in  their capacity to move through a fibronectin - coated membran  under basal conditions  or with support of  SDF - 1α, VEGF or Interleukin - 8 stimulation (Fig.3.3.2).  3. Results     25       Figure 3.3.2: Adhesion capacity of EPCs subjected to caspase - 8 inhibition   EPC  migration  was  conducted  in  Boyden  Chambers  with  SDF1α  (100   ng/ml)  (a),  VEGF  (50   ng/ml) (b) and IL - 8 (50   ng/ml) (c) for 18  h after preincubation with zIETD for 6 h. *   p<0.05;  n=3 (mean ± SEM)     In contrast  to EPCs ,  HUVECs  remained adherent on uncoated plastic dishes even in  the  prolonged  presence  of  high  doses  of  caspase   inhibitors   (data  not  shown).  In  order to analyse the ef fect of caspase inhibition on the migratory capacity, HUVECs  were first preincubated with different caspase inhibitors and subsequently subjected  to a scratch wound assay.  HUVEC  migration  was not affected by  caspase inhibitors   ( Fig.3.3.3a). HMVEC migration  was also not affected by caspase inhibitors tested in  a boyden chamber migration (Fig.3.3.3b). These results suggest  that the dependency  of adhesion and migration on  caspase  activity is restricted to   early  circulating blood - derived cells.   3. Results     26                   Fi gure 3.3.3: Migration of HUVEC in a scratch wound assay   (a) Pretreated (16 h with inhibitors) HUVECs migrated in a scratch wound assay for 24 hours  in the presence of different caspase inhibitors (100   µM). (b) HMVEC were pretreated with  different caspase i nhibitors (100   µM) for 35 hours and migrated in boyden chamber for 5  hours. (both assays n=3, mean ± SEM, not significant)   These data indicate that caspase - 8 is required for matrix adhesion and migration of  endothelial  precursor  cells  which  are  known  for  t heir  potential  in  promoting  neovascularization but not for these functions of mature endothelial cells.     3.4   Caspase - 8 inhibition plays a role in cytokine release   To test whether caspase - 8 is involved in cytokine secretion, we analyzed the culture  medium of EP Cs. Caspase - 8 inhibition by zIETD profoundly disturbed the cytokine  release by EPCs. The chemokine stromal cell - derived factor (SDF) - 1α, ligand for the  CXCR4 receptor, and the hepatocyte growth factor (HGF) were significantly reduced  after 3 days of  ex viv o  cultivation compared to the solvent (Fig.3.4.1a,b). In contrast,  the i nsulin - like - growth factor - 1 (IGF - 1) was  slightly upregulated in EPCs cultured for 3  days in the presence of the caspase - 8 inhibitor (Fig.3.4.1c).   3. Results     27          Figure 3.4 .1: Growth factor release of caspase - 8 inhibitor treated EPCs   (a,b) Significant reduction of growth factor SDF - 1 α and HGF release into the culture medium  by endothelial precursor cells was observed after 3 days in  ex vivo  culture in the presence of  caspase - 8 inhibitor (100   µM). * p<0.05 (c) IGF - 1 was slightly increased in the presence of  zIETD  in  the  culture  medium  compared to  control  cells.  In  both  experiments,  the growth  factors were measured by ELISA. n=3 (mean ± SEM)     3.5   The activity of caspase - 3 is not increased in adherent EPC    These previous data indicate that caspase - 8 is required for formation and function of  p rogenitor  cells  ex  vivo .  Disturbance  of  EPC  formation  and  adhesion  could  be  a  consequence of apoptosis pathway induction. As a matter of fact, caspase - 8 activity  was detected in the majority of the cultured adherent cells (EPC day 3) under basal  conditions  compared to freshly isolated mononuclear cells and the suspension cells  at day 3 (Fig.3.5.1a). Caspase - 3 is a known target of caspase - 8 to trigger apoptosis  pathway induction  (Boatright and Salvesen 2003) . However,  the higher  c aspase - 8 3. Results     28     activity  in  the  adherent  cells  was  not  associated  with  an  increase   in  c aspase - 3  activity (Fig.3.5.1b).                             Figure 3.5.1: Caspase - 8 and  - 3 activities in human endothelial precursor cells   Caspase - 8 (a) and  - 3 (b) activities were measured in fresh isolated cells (mononuclear cells),   suspension cells (72 hours after isolation) versus adherent EPCs at day 3 of  ex vivo  culture   in a microplate reader . * p<0.05; mean ± SEM, both n=3.    Th e s e  results support  our   idea  that basal caspase - 8 activation in adherent day 3  EPC s  is  to low  to activa te the apoptosis cascade pathway.  In contrast, caspase - 3  activity  was  observed  in  non - adherent  mononuclear  cells  cultured  for  72  hours  resulting  in  a  higher  apoptosis  rate  and  a  short  life - span  (Fig.3.5.1b).  These  observations  agree  with  apoptosis  measurem ents,  showing  more  apoptotic  cells 3. Results     29     within the suspension cell population compared to the fibronectin - adherent EPCs at  day 3 of  ex vivo  culture (Fig.3.5.2).                            Figure 3.5.2:  Measurement of apoptotic cells with Annexin V by flow cytometr y   Suspension  cells  were  compared  with  adherent  cell  at  day  3  in  ex  vivo   cell  culture.  Suspension  cells  were  slightly  higher  in  their  amount  of  apoptotic  cells  compared  to  the  adherent cells. The percentage of apoptotic cells of all measured cells is indica ted in the  graph. n=3, p=0.06   To prove that the caspase - 8 inhibitor zIETD specifically affects caspase - 8 activity, we  used a caspase - 8 colorimetric assay by Sigma ® . EPCs were washed and incubated  for 5 hours with 0% EBM medium without any growth factors an d 3 hours with TNF a   (50 ng/ml) to induce an increase in intracellular caspase - 8 activity. Cell lysates were  incubated  with  Acetyl - Ile - Glu - Thr - Asp - p - Nitroaniline   (Ac - IETD - pNA) ,  simulating  a  caspase - 8 substrate, and additionally with zIETD inhibitor (100µM). Hydrolysis of the   applied substrate results in the release of p - Nitroaniline  (p - NA) measured at 405nm.  The outcomes show a strong decrease of p - NA release after incubation of the cell  lysate  with  the  caspase - 8  inhibitor  zIETD  (Fig.3.5.3)  proving  its  specific  inhibitory  eff ect on caspase - 8.  3. Results     30                       Figure 3.5.3: Caspase - 8 activity assay    Cell lysates of adherent EPCs incubated for several hours with 0% EBM and TNF α were  checked for their caspase - 8 cleavage activity (control) as well as in the presence of caspase - 8 inhibitor (zIETD).  * p<0.03;  n=6     3.6   I n  vivo   incorporation  and  improvement  of  neovascularization  by  transplanted human outgrowing precursor cells is reduced  by caspase - 8  inhibition    In order to test, whether the observed reduction  of adhesion and migration of cultured  endothelial progenitor cells by the  c aspase - 8 inhibitor leads to an impaired  in vivo   homing, cultured EPC were  ex vivo  pre - treated with  a low  d ose  of  zIETD  (20µM)  for  18 hours and intravenously injected in to   nude  mice  24 hours after  hind limb ischemia.  Harvesting of the muscles 72 hours after hind limb ischemia was followed by staining  of frozen sections for human nuclear antigen indicative for e ngrafted human cells and  with the DNA - fluorescence dye DAPI. Engrafted  EPC s  were detected in the ischemic  tissue  with fluorescence microscopy . Pretreatment with zIETD significantly reduced  incorporation of infused cells 48 ho urs after administration (Fig.3 .6.1 a). Moreover,  perfusion  of  matrigel  plugs  stimulated  by  EPC  injection  was  significantly  reduced  after  ex vivo  pretreatment with  zIETD (Fig.3.6.1 b) indicating that cell autonomous  c aspase - 8  activity  indeed  contributes  to  in  vivo   homing  and  improvement  o f  neovascularization mediated by infused pro - angiogenic cells.  3. Results     31          Figure 3.6.1: Effect of caspase - 8 inhibition on vascularization  in vivo   Intravenously admitted human EPCs were pretreated with caspase - 8 inhibitor or solvent as  control.  (a)  Numbers  of  huma n  nuclear  antigen +   (HNA)  presenting  cells  were  counted  in  frozen sections from murine hind limb tissue 2 days after ischemia . (b) The perfusion of  matrigel was quantitatively assessed after transplantation of  EPCs pretreated with caspase - 8  inhibitor or sol vent ( * p<0.05; mean ± SEM, n=5 plugs per group) .   Additional  to  the  detection  of  engrafted  human  EPCs  in  ischemic  tissue,  post - ischemic neovascularization was observed by blood flow ratio two weeks after EPC  transplantation  between  PBS - treated  mice,  EPC  an d  zIETD - pretreated  cells  (Fig.3.6.2).  3. Results     32                              Figure 3.6.2: Effect of caspase - 8 inhibition on neovascularization in ischemic tissue in  vivo   Pretreated human EPCs (solvent vs. zIETD 20   µM for 18 h) were transplanted into nude  mice  following  femoral  artery  ligation  to  induce  ischemia.  Enhancement  of  post - ischemic  neovascularization by human EPCs measured by Laser Doppler given as the blood flow ratio  of  the  ligated  vs.  unligated  limb.  Caspase - 8  inhibition  reduced  the  neovascularization  capacit y of EPCs; * p<0.05 vs. PBS - treated nude mice,  mean ± SEM,  n=4 per group.     3.7   Caspase - 8 deficiency  in vivo  reduces functionality and  vascularization  capacity of bone marrow mononuclear cells    Our  ex  vivo   studies  give  rise  to  the  idea  that  caspase - 8  is  essenti al  for  EPCs.  Caspase - 8  deficient  mice  are  embryonically  lethal  because  of  a  reduced  hematopoietic  progenitor  pool,  limited  heart  development  and  hyperemia  (Varfolomeev, Schuchmann et al. 1998) . These results already   claim a high non - apoptotic  function  of  caspase - 8  in  vascularization  and  angiogenesis.   Because  of  failed  knockdown  on  mRNA  level  by  lentivirus  transduction  in  EPC  compared  to  HUVECs  (Fig.3.7.1), we were not able to continue  ex vivo  experiments combined  wi th silencing of the caspase - 8 gene.  3. Results     33                           Figure 3.7.1: Caspase - 8 knockdown by Lentivirus   Lentiviral transduction of a hairpin RNA against caspase - 8 for silencing of the caspase - 8  mRNA  in  HUVECs  and  EPCs.  Various  caspa se - 8  sequences  (Sigma - Aldrich)  showed  different  knowndown  efficiency  in  HUVECs  (red  rectangle)  compared  to  no  reduction  in  EPCs by RT - PCR.   To elucidate the in vivo relevance of caspase - 8, we used a mouse model in which  exon  1  and  2  of  the  caspase - 8  gene  is   conditionally  deleted  by  the  cyclization  recombination  enzyme  (Cre)  under  control  of  the  inducible  Interferon - responsive  myxovirus resistance - 1 (Mx1) promoter.  This promoter is silent in mice  as long as the  transcription  levels  is not  induced by adm ission  of interferon   γ , or  as in our case with  synthetic  double - stranded  RNA  poly  I:C  (pI - pC) .   One  allel  is  knocked  out  (heterozygous)  whereas  the  other  is  flanked  by  loxP   recognition  sites.  The  homozygous gene deletion is induced by Cre expression under the control of the  Mx1  promoter in a tissue -  and time - dependent manner  (Kuhn, Schwenk et al. 1995) .  The  Mx1  promoter  targets  hematopoietic  precursor  cell  development  resulting  in  reduced bone marrow functionality. Progeni tor cells isolated from spleen, lymph node  and liver after pI - pC injection showed reduced functionality  (Kang, Ben - Moshe et al. 3. Results     34     2004) . Caspase - 8 deletion in mice was checked with primers detecting the floxed,  the no n - floxed and the deleted allele  (Kang, Ben - Moshe et al. 2004)  (Fig.3.7.2).                                                              Figure 3.7.2:  Caspase - 8 deletion in mice   Caspase - 8  deletion  was  checked  by  RT - PCR  in  b one  marrow  cells  from  mice  to  detect  caspase - 8 deletion. A primer set of three was used to check for deleted, floxed and non - floxed alleles. GAPDH primers were used as loading control.     Because of the limited blood volume in mice, it is impossible to isola te circulating  mononuclear cells. For this reason, we used spleen mononuclear cells  from different  genetic  caspase - 8 - deficient  mice   to  compare  the  capacity  to  form  fibronectin - adherent  EPCs.  The  number  of  ex  vivo   adherent  EPCs  cultured  for  4  days  in  endoth elial basal medium was counted in a fluorescence microscope after uptake of  Dil - Ac - LDL .  Cells  derived  from  caspase - 8 - deficient  mice  ( Casp8 F / - :Mx1 - Cre  mice  after pIpC treatment ), showed a reduced capacity to form fibronectin - adherent EPCs  compared to cells  obtained from control animals (Fig.3.7.3).                                3. Results     35     Figure 3.7.3:  Ex vivo  formation of mouse EPCs bearing Caspase - 8 deletion.   Induced caspase - 8 deletion in mice reduced the ability to form fibronectin - adherent splenic  EPCs after 4 days  in culture. Cells coming from mice with two functional caspase - 8 alleles  had a higher capacity in EPC formation, mean ± SEM, n ≥3.   It has already been published that bone marrow cells improve neovascularization and  angiogenesis in injured tissue  (Assmus, Schachinger et al. 2002)   (Schachinger, Erbs  et al. 2006) . To address whether caspase - 8 gene deletion influences bone marrow  cells in their capacity to improve  post - ischemic  neovasculariz ation, we infused bone  marrow cells  into nude mice  following femoral artery ligation in the right hind limb.  Bone  marrow  mononuclear  cells  from  conditional  c aspase - 8 - deficient  mice  had  a  significantly reduced capacity for enhancing limb perfusion when tran splanted into  mice  in  comparison  with  cells  from  mice  with  two  functional  c aspase - 8  alleles   (Fig.3.7.4). These  ex vivo  and  in vivo  results demonstrate that caspase - 8 deletion  plays  a  crucial  role  in  cell  homeostasis  and  confirmed  that  caspase - 8  activity  is   required  for  cell  functionality  and  progenitor  cell - mediated  improvement  of  neovascularization  in vivo .                            Figure  3.7.4:  Post - ischemic  neovascularization  of  bone  marrow  mononuclear  cells  from mice with a conditional caspase - 8 deletion   Bone  marrow  mononuclear  cells  with  a  caspase - 8  deletion  have  a  reduced  neovascularization  capacity  compared to  cells with  two  functional  caspase - 8  alleles. One  million  cells  were  intravenously  infused.  Two  weeks  later,  blood  flow  of  hind  limbs  was 3. Results     36     measure d  with  a  laser  Doppler  blood  flow  meter.  The  blood  flow  ratio  based  on  the  comparison of ischemic to non - ischemic hind limb perfusion.  No cells were infused in the  PBS group.   ( * p<0.05 vs. PBS), n=4 animals per group.   Moreover, capillary density  from hind  limb muscles was analyzed by staining frozen  sections with antibodies against CD31 +  and laminin to visualize small new capillaries  around existing myocytes. Caspase - 8 - deficiency   reduced the functional capability of  bone marrow mononuclear cells to increase  capillary density after hind limb ischemia  (Fig.3.7.5), and supported our idea that caspase - 8 is indeed required for precursor  cell - mediated functional improvement of neovascularization  in vivo .     3. Results     37                    Figure 3.7.5: Fluores cence images of capillary density from hind limb of nude mice   Stainings of frozen sections from the right hind limb following hind limb ischemia and infusion  of bone marrow cells from mice with induced caspase - 8 deletion or control mice without Cre  (PBS (1 00%) vs. Casp8 F/ - :Mx1 - Cre(103%) vs.Casp8 F/+ (124%)). Muscles were harvested two 3. Results     38     weeks  after  ischemia.  Numbers  enclosed  in  brackets  indicate  the  ratios  of  capillaries  to  myocytes (ratio of PBS group was set to 100%).   Surface receptors like integrins and CXCR 4 are important for homing, vascularization  and angiogenesis  (Chavakis, Aicher et al. 2005)   (Yamaguchi, Kusano et al. 2003)   (Walter,  Haendeler  et  al.  2005) .  FACS  analysis  revealed  that  bone  marrow  mononuclear cells from induced caspase - 8 - deficient mice ex press significantly lower  levels  of  integrin  alpha5,  CXCR4  and  integrin  alpha4.  In  vivo ,  the  expression  of  VEGF - R2  (KDR)  did  not  change  significantly  after  Cre  recombinase  induction  by  interferon γ (Fig.3.7.6a - d).      Figure 3.7.6: FACS analysis of mice BMC   Double - staining of mice BMCs with antibodies against integrin alpha5, CXCR4, VEGFR2 and  integrin  alpha4  combined  with  c - Kit  or  Sca - 1  (markers for  hematopoietic  progenitor  stem  cells). Comparison of BMCs of control mice (Casp8 Flox/+ ) with cells of mice wit h caspase - 8  deletion  (Casp8 F/ - :Mx1 - Cre)  after  Cre  recombinase  induction  ( *  p<0.05  vs.   Casp8 F/ - :Mx1 - Cre ), n=3 animals per group.     3. Results     39     3.8   Cell surface receptor regulation by caspase - 8 inhibition   Because  of  the  reduced  cell  surface  expression  of  integrin  alpha5,  CX CR4  and  integrin alpha4 in caspase - 8 deficient BMCs, we investigated possible downstream  effectors influencing surface receptors in EPCs.    We performed FACS analysis of EPCs following caspase - 8 inhibition by zIETD. We  tested the EPCs for different adhesion  and homi ng molecules. As already shown  treatment with 100 µM zIETD induced irreversible detachment of the cells (Fig.3.3.1).  FACS analysis showed that the fibronectin receptor subunits integrin alpha5 and to a  lower extent integrin beta1 are reduced on th e cell surface after caspase - 8 inhibition  (Fig.3.8.1a).  Furthermore,  the  vitronectin  receptor  subunits  αVβ5  and  αVβ3  are  significantly reduced on the EPC surface, but not as strong as the integrin subunit  alpha5 (Fig.3.8.1b). Additional analysis of CD18 an d CD11a,b,c (Fig.3.8.1c) showed  only significant reduction in CD11a after 3 h of treatment with zIETD and zVAD, a  pan inhibitior for all caspases.    3. Results     40                Figure 3.8.1:  FACS analysis of EPCs    (a - c) Analysis of different adhesion molecules of the integr in family on the cell surface of  EPCs  by  fluorescence  activated  cell  sorting  followed  by  caspase  inhibition  (100   µM),  *   p<0.05 vs. control, each n=3.   Consistent  with  the  oberservation  that  inhibition  of  caspase - 8  impairs  SDF1 α   stimulated migration (Fig.3.3.2a), pharmacological caspase - 8 inhibition targets  C - X - C  chemokine  receptor  type  (CXCR4)  surface  expression  on  EPCs.  There  is  a  significant  reduction  in  CXCR4  on  EPC  (Fig.3.8.2a).  Similar  but  less  pronounced  results were obta ined for VEGF - R2 expression (Fig.3.8.2b).    3. Results     41       Figure 3.8.2: CXCR4 and VEGF - R2 surface expression is dependent on caspase - 8   FACS analysis of EPCs after 4 hours of caspase - 8 (zIETD) or caspase - 3 and  - 6 (zDQMD)  inhibition (100   µM), * p<0.05 vs. DQMD, n=4.   Bec ause of the strong reduction of integrin alpha5 on the cell surface analyzed by  FACS, we checked for the protein expression of the fibronectin subunits alpha5 and  beta1. Western blot analysis showed a reduction in protein levels of integrin alpha5  followin g  caspase - 8  inhibition  by  zIETD  (Fig.3.8.2a)  but  not  of  beta1  expression  (Fig.3.8.2b). Protein expression was compared with cell extract derived from EPCs  pretreated with zDQMD ( inhibits  c aspase - 3 and  - 6 ).                       Figure 3.8.2: Western blot from  EPC    (a, b) Integrin alpha5 and beta1 protein detection following ex vivo treatment of endothelial  precursor cells with caspase inhibitors (100   µM) for 4 hours. Caspase - 8 inhibition by zIETD  significantly reduced integrin alpha5 protein expression compare d to control (solvent) and  zDQMD but not beta1 protein expression. (a) n=5, (b) n=4  3. Results     42       Figure 3.8.3:   Integrin alpha5 expression after zIETD short - time treatment.   Representative confocal microscopy images of paraformaldehyd – fixed EPCs after caspase - 8  inhib ition by zIETD (100   µM) for 30 min and staining with antibody against integrin alpha5,  DNA - fluorescence dye DAPI and anti - nucleosom (anti - Nuc).  3. Results     43     EPCs, which  were treated with zIETD for 30 minutes, were fixed and stained for  integrin alpha5, DAPI and anti - nu cleosom. Already short - time incubation with zIETD  reduced the expression level of integrin alpha5 in EPCs compared to untreated cells  (Fig.3.8.3).   To determine whether the reduction of the alpha5 subunit is sufficient to explain the  reduced  adhesion  shown  after  zIETD  treatment,  we  co - incubated  EPCs  with  a  neutralizing integrin alpha5 antibody. As shown in Figure 3.8.4, indeed, blocking the  integrin  alpha5  subunit  significantly  reduced  the  adhesion  of  EPCs  to  the  matrix  protein fibronectin.                                Figure 3.8.4:  EPC adhesion on fibronectin   Cell adhesion to fibronectin was significantly reduced following incubation with a neutralizing  antibody against integrin α5 for 6 hours, * p<0.005 vs. iso - IgG antibody as control; n=4     3.9   Caspase - 8 targets  Cbl - b   Many caspase  substrates have been identified in the past  (Kang, Ben - Moshe et al.  2004)   (Frisch 2008)   (Maelfait and Beyaert 2008) .   Potential candidates to modulate  the  migration  and  adhesio n  capacities  of  EPC s   are  the  Cbl  E3  ubiquitin  ligases,  which were  identified to be degraded in a c aspase - 8 - dependent manner  (Widmann,  Gibson  et  al.  1998) .  Cbl  proteins  act  as  negative  regulators  of  various  signal  transduction protein s  involved in cell migration and attachment (reviewed in  (Schmidt 3. Results     44     and  Dikic  2005) ) .  Expression  profiling  revealed  that  among  the  Cbl  proteins  the  isoform Cbl - b is particularly highly expressed in EPC (Fig. 3.9.1 ).                          Figure 3.9.1: Cbl expression in different cell  types   In a microarray, the mRNA expression level of Cbl protein was detected. The Cbl - b isoform  was significantly higher in EPC compared to CD34 + , monocytes (Mono) and HUVEC. c - Cbl  isoform was low expressed in EPC similar to HUVEC and monocytes. n=3, * p< 0.05 (mean ±  SEM)   In order to test, whether Cbl - b is a target  of   c aspase - 8 , we overexpressed Cbl - b  wildtype in HEK293 cells.    As shown before, caspase - 8 inhibition leads to integrin alpha5 reduction (Fig.3.8.2).  Further, caspase - 8 inhibition by the pharmac ological substrate zIETD increased Cbl - b  protein  level  in  EPC  (Fig.3.9.2).  These  results  could  be  a  first  hind  for  signal  transduction from caspase - 8 to Cbl - b and this in turn leading to the downregulation of  integrin alpha5.    3. Results     45                                   Figure 3.9.2: Protein analysis of stimulated EPC   EPCs  were  treated  with  cas pase  inhibitors  (100   µM,  4   h ),  and  protein  was  detected  by  Western blot. Cbl - b protein was upregulated in the presence of caspase - 8 inhibitor compared  to control and zDQMD. ERK1/2 w as used as loading control. n=6   Because  of  the  inefficient  lentiviral  transduction  in  EPCs  (Fig.3.7.1),  further  experiments were performed in HEK293 cells. In HEK293 cells, endogenous as well  as overexpressed wild type Cbl - b was degraded in the presence of  simultaneously  overexpressed caspase - 8 (Fig.3.9.3).                               Figure 3.9.3: Simultanous overexpression of Cbl - b and caspase - 8 in HEK293 T  cells   Endogenous  and  overexpressed  protein  of  Cbl - b  in  HEK293  cells  was  degraded  in  the  presence of s imultanously overexpressed caspase - 8. Antibody against Tubulin was used as  loading control. n=3   These  results  support  the  hypothesis  that  caspase - 8  targets  Cbl - b  in  EPCs.  Additionally, overexpression of Cbl - b in HEK293 cells and subsequent incubation of  th e  cell  lysate  with  recombinant  caspase - 8  protein  showed  a  decrease  in  Cbl - b  protein amount (Fig.3.9.4).     3. Results     46       Figure 3.9.4: Cell - free cleavage of overexpressed Cbl - b   Overexpression of Cbl - b wildtype protein and incubation of the cell lysate with recombinant  caspase - 8  (2   Units)  at  37°C  for  the  indicated  periods  of  time  showed  a  decrease  in  the  overexpressed protein, n=3.   Afterwards, immunoprecipitation of overexpressed Cbl - b followed by incubation with  recombinant caspase - 8 revealed an effective degradation of  Cbl - b protein (Fig.3.9.5).  These results suggest that caspase - 8 targets Cbl - b and thereby, indirectly influences  integrin alpha5 protein expression.                         Figure 3.9.5: Degradation of Cbl - b protein by caspase - 8   Overexpression of Cbl - b in HEK 293 cells was followed by immunoprecipitation against HA - Tag  with  specific  antibody  (Roche ® ).  In  vitro   degradation  of  immunoprecipitated  Cbl - b  protein was performed using recombinant Caspase - 8 for 30 min, n=3.   Using different truncated Cbl - b constructs, we  aimed to identify the cleavage site of  caspase - 8 inside Cbl - b (Fig.3.9.6). These constructs have overlapping regions.      3. Results     47       Figure 3.9.6: Truncated Cbl - b constructs   Schematic presentation of different truncated Cbl - b plasmid constructs based on the Cbl - b  w ildtype (kindly provided by I.Dikic group, Institute of Biochemistry, Frankfurt).    Truncated  Cbl - b  constructs  (which  are  kindly  provided  by  I.Dikic)  were  strongly  overexpressed with exception of Cbl - b N1/3. In this case, overexpression appeared  to be very  low. But caspase - 8 cleaved all Cbl - b constructs (Fig.3.9.7) resulting from  more than one cleavage site. Cleaved fragments are not detected assuming a fast  degradation or instability of the dysfunctional elements.    3. Results     48                           Figure 3.9.7: Simultanous overexpression of truncated Cbl - b constructs with caspase - 8 wildtype   Simultanous  overexpression  of  HA - epitope  tagged  Cbl - b  fusion  proteins  and  caspase - 8  wildtype  in  HEK293  cells  with  Superfect  reagent.  Detection  of  the  Cbl - b  cons tructs  with  antibody against HA - Tag, n=3.    These  data  strong ly   indicates  that  c aspase - 8  regulates  indire ctly  the  f ibronectin  subunit integrin alpha5 in EPC via the E3 ubiquitin - protein ligase  Cbl - b .      3.10   Cbl - b influences angiogenesis   Because of the limited tr ansfection efficiency in EPCs, in vitro downregulation of Cbl - b was investigated in HUVEC. A specific siRNA targeting Cbl - b was used to down 3. Results     49     regulate  Cbl - b.  Down  regulation  was  confirmed  by  semiquantitative  RT - PCR  (Fig.3.10.1).                              Fig ure 3.10.1: Expression and knockdown of Cbl - b   HUVEC  were  transfected  with  siRNA  targeting  Cbl - b  using  Superfect  reagent.  mRNA  expression level was detected by RT - PCR 24 hours after transfection. GAPDH served as  loading control.   After siRNA transfection, HU VECs were subjected to a three - dimensional angiogenic  spheroid assay to analyze sprouting capacity  in vitro . Indeed, Cbl - b downregulation  leads to an increase in endothelial cell sprouting under   basal conditions and suggest  that Cbl - b has a critical role i n angiogenic activity (Fig.3.10.2).       Figure 3.10.2: Spheroid assay of HUVEC after downregulation of Cbl - b   (a)  HUVECs  were  transfected  with  Cbl - b  siRNA  or  scrambled  oligonucleotides.  Spheroid  assays  were  performed  to  analyze  basal  endothelial  cell  sprouti ng  capacity.  Sprouting  capacity  is  given  as  cumulative  sprout  length  per  spheroid,  *  p<0.05  vs.  scramble  (Scr)  (mean±SEM), n=3. (b) Representative spheroids are shown for scrambled and Cbl - b siRNA.   3. Results     50     To  assess  if  the  observed  pro - angiogenic  effect  in  vitro   is  based  on  enhanced  migration, we used Cbl - b siRNA treated HUVECs in the boyden chamber migration  assay  to  address  this  aspect.  Cbl - b  knockdown  in  HUVEC  significantly  increased  migration.  These  results  are  consistent  with  the  angiogenic  skills  of  Cbl - b - si RNA - transfected HUVECs in the spheroid assay (Fig.3.10.3).                               Figure 3.10.3: HUVEC migration after Cbl - b siRNA knockdown   HUVECs  were  transfected  with  siRNA  oligonucleotides  against  Cbl - b  and  scrambled  sequence (Scr). Migration was pe rformed in fibronectin coated boyden chambers for 5   h.  After  fixation  of  the  cells,  DAPI  staining  was  used  to  count  migrated  cells.  *  p<0.05  vs.  scramble (mean±SEM), n=3.       3.11   Cbl - b in vascularization in vivo   Having demonstrated that  c aspase - 8 targets Cbl - b i n EPC s , we next tested whether  Cbl - b modulates angiogenesis  in vivo .  For this purpose, a Cbl - b knockout mouse  model  was  used  to  investigate  involvement  of  Cbl - b  in  vascularization  and  angiogenesis  (Bachmaier, Krawczy k et al. 2000) .   3. Results     51       Figure 3.11.1: Involvement of Cbl - b in angiogenesis  in vivo   Vascularization of matrigel plugs in Cbl - b - deficient mice were compared to wild type animals,  measured by quantification of smooth muscle actin positive vessels, * p<0.05 (mean ±SEM),  each group n=7.   Vascularization was detected and quantified in paraffin - embedded matrigel plugs by  staining for smooth muscle actin. Indeed, vascularization of matrigel plugs implanted  in the back of Cbl - b deficient mice was strongly increased compa red to wild type  mice (Fig.3.11.1a/b).    In a hind limb ischemia model, post - ischemic perfusion was more effectively rescued  by  transplanted  bone  marrow  progenitor  cells  derived  from  Cbl - b - deficient  mice  (Fig.3.11.2)  compared  to  BMCs  from  wild  type  mice.  Th us,  Cbl - b  could  act  as  a  negative regulator of vasculogenic  precursor  cell function and angiogenesis  in vivo .                           3. Results     52     Figure  3.11.2:  Post - ischemic  neovascularization  of  transplanted  bone  marrow  mononuclear cells from Cbl - b deficient mice   Aft er two weeks, neovascularization in femoral artery ligated nude mice was enhanced after  the transplantation of bone marrow mononuclear cells derived from Cbl - b - deficient (Cbl - b - / - )  mice compared to wild type BMCs, measured by Laser Doppler. Flow rate is gi ven as ratio of  the ligated vs. contralateral limb; * p<0.05 (mean±SEM), n=6 per group.     3.12   Regulation of Caspase - 8    Having  demonstrated  that  EPCs  reduce  the  release  of  cytokines  like  chemokine  stromal cell - derived factor (SDF)   - 1 and hepatocyte growth factor  (HGF) (3.4.) under  pharmacological  caspase - 8  inhibition,  we  questioned  how  caspase - 8  is  further  regulated  besides  the  known  apoptosis  induction  by  death  receptors  like  TNF  or  Fas?  One  possible  opportunity  could  be  the  influence  of  cytokines  as  well  as  med iators from the inflammatory tissue.    In  a  three  day  culture  assay,  Interleukin - 6  significantly  increased  the  fibronectin - adherent  endothelial  precursor  cells  (Fig.3.12.1)  as  measured  by  counting  cells  taking up Ac - Dil - LDL.                            Figure 3.12.1:  Effect of Interleukin - 6 on EPC formation    Mononuclear cells were isolated from blood and cultured for 72 hours in the presence of  Interleukin - 6 (5 or 10ng/ml). The number of adherent EPCs increased in combination with 3. Results     53     interleu kin - 6  stimulation.  Formation  of  adherent  precursor  cells  was  counted  with  a  microscope after staining the cells with Dil - Ac - LDL and vWF,  * p<0.05 (mean±SEM), n=5.   Furthermore,  Western  blot  analysis  of  EPC  lysates  showed  that  IL - 6  stimulation  decreased Cbl - b protein amount (Fig.3.12.2).                          Figure 3.12.2: Protein expression of Cbl - b after Interleukin - 6 stimulation   Mononuclear  cells  were  isolated  and  cultured  ex  vivo   72  hours  in  combination  with  Interleukin - 6.  Cbl - b  protein  was  detected  with   a  specific  antibody  (Santa  Cruz).  The  expression of Cbl - b was decreased with an increased stimulation of interleukin - 6. n=3.   Furthermore, FACS analysis of integrin alpha5  in day 3 EPC s   confirmed this possible  caspase - 8  regulation  and  matched  to  the  previo us  data.  Integrin  alpha5  was  significantly increased in EPCs treated with Interleukin - 6 (Fig.3.12.3).                              Figure 3.12.3: Integrin alpha5 expression on EPC after Interleukin - 6 stimulation   Integrin alpha 5 surface  expression on EPCs was significantly increased after interleukin - 6 (5  and 10   ng/ml) stimulation measured by flow cytometry, * p<0.05 vs. control (mean±SEM),  n=8.4. Discussion     54     4.   Discussion   Endothelial  progenitor  cells  comprise  a  therapeutic  neovascularization - promoting  p otential after ischemia which is due to survival and retention of the infused cells in  the ischemic tissue. Caspases are   mainly  described  as mediators in the apoptotic  pathway induction. However, detailed investigations in the past decade revealed that  cas pases  are  additionally  involved  in  other  biological  processes  like  migration,  proliferation and differentiation (reviewed in  (Launay, Hermine et al. 2005)   (Lamkanfi,  Festjens et al. 2007) ). Since caspase function in endothelial precursor cells is mainly  unknown so far, this study is basically focussed on the function of Caspases and  their non - apoptotic targets in EPC regulation.      4.1   Characterization of  endothelial progenitor cells   Endothelial precursor cells are a heterogeneous cell population, mostly isolated from  peripheral  (Asahara, Murohara et al. 1997)  or umbilical cord bloo d  (Murohara, Ikeda  et al. 2000)  and bone marrow  (Lin, Weisdorf et al. 2000) . The mononuclear cells  isolated from peripheral blood by ficoll density gradient centrifugation and cultured in  endothelial differentiation conditions express endothelial, myeloid and hematopoietic  markers  (Fig.3.1.1).  The  expression  of  endothelial  marker  protein  VEGF - R2,  von  Willebrand factor (vWF) and lectin binding was shown by FACS analysis, whereas  endothelial  nitric  oxide  synthase  (eNOS)  was  previously  described  by  our  group  (Dernbach, Urbich et al. 2004)   (Cha vakis, Aicher et al. 2005)  as well as uptake of Ac - LDL.  However,  since  EPC  does  not  express  cell  specific  markers,  they  are  still  difficult to characterize. EPC are divided into early and late stage subpopulations  because  of  variations  in  expression  level s  of  different  markers  (Hur,  Yoon  et  al.  2004) .  After  prolonged  cultivation,  cells  maturate  and  simultaneously  endothelial  marker  genes  further  increase.  Currently,  isolated  and  cultured  cells  used  in  our  studies  mi ght  be  characterized  as  early  EPC  because  of  parallel  expression  of  hematopoietic  and  endothelial  markers.  They  express  the  neutrophil  and  macrophage marker  CD31 and vascular endothelial (VE) - cadherin  (Dimmeler, Aicher 4. Discussion     55     et al. 2001)  as wel l as the hematopoietic leukocyte marker CD45  (Urbich, Heeschen  et al. 2003)  and stem cell homing receptor CXCR4.    Variations in isolation and culture co nditions of EPC have been shown to influence  the  subpopulation  as  well  as  the  differentiation  status  and  subsequently  the  expression of protein markers  (Eggermann, Kliche et al. 2003)   (Seeger, Tonn et al.  2007) .       4.2      Selection of Caspase - 8 as an important player in EPC function    Caspases are pro - apoptotic enzymes but investigations allocate them non - apoptotic  roles  in  many  species  and  cell  types  (Lamkanfi,  Festjens  et  al.  2007) .  Pharmacological  inhibitors  are  commercially  available  to  competitively  and  irreversibly inhibit caspases by mimicking substrates.  At the beginning of th is study  we  planned  to  use  caspase  inhibition  to  improve  incorporation  and  survival  of  therapeutically  applied  EPC  in  ischemic  tissue.  Sordet  et  al.  showed  that  several  short  term  active  caspases  in  peripheral  blood  monocytes  are  involved  in  the  differenti ation into macrophages, and this process was blocked by caspase inhibitors  (Sordet, Rebe et al. 2002) .  We also could show in first experiments that caspases  have other tasks in EPC besides apoptosis induction.  Surpr isingly,  in our hands  the  pan caspase inhibitor as well as the specific caspase - 8 inhibitor zIETD completely  abrogated the adherence of EPC on fibronectin  in vitro  (Fig.3.1.2 a,b).  Additionally, in  our hands  ex vivo  zVAD treated EPC lost their ability in a dhesion and migration.  These  findings  assumed  a  novel  role  of  Caspase - 8  in  EPC  formation   and  EPC  retention in injured tissue  and could be helpful for better understanding the progenitor  cell - mediated  neovascularization .  Moreover  previous  observations  demon strate  already  an  essential  function  of  caspase - 8  in  endothelial  cells  during  embryonic  vascular development and hemopoiesis  (Kang, Ben - Moshe et al. 2004) .     4. Discussion     56     4.3   Low Caspase - 8 expression in HUVEC   Having shown that treat ment of EPC with the pan caspase inhibitor zVAD as well as  the  specific  Caspase - 8  inhibitor  zIETD  resulted  in  inhibition  of  formation  and  adhesion of EPC, we aimed to analyze the caspase - 8 functions in peripheral blood  mononuclear cell - derived EPC in more  detail. Caspases are synthesized as inactive  proenzymes containing 3 domains: a N - terminal domain, a large subunit and a small  subunit.  Recruitment of caspase - 8 by adaptor proteins like FADD (Fas - associated  protein  with  death  domain)   leads  to  its  auto - acti vation   followed  by  a  heterodimer   formation   (Thornberry  and  Lazebnik  1998) .   The  expression  of  caspase - 8  itself  is  regulated by alternative splicing. In the literature, several isoforms are described for  caspase - 8  (Boldin, Goncharov et al. 1996) . Caspase - 8 a/b comprise the complete  forms  which  are  known  to  mediate  apoptosis.  One  alternative  splice  variant  of  caspa se - 8 is caspase - 8L  (Horiuchi, Himeji et al. 2000) . Caspase - 8L transcript carries  a 136 bp insertion finishing in a premature termination by a stop codon. The protein  carries  two  repeats  of  DED  of full - length  caspase - 8  N - terminally  but  lacks  the  C - terminal  proteolytically  active  domain.  Caspase - 8L  is  described  as  endogenous  inhibitor  of  caspase - 8  by  binding  to  FADD  (Fas - associating  protein  with  death  domain) and caspase - 8 and interferes the binding between them  (Himeji, Horiuchi et  al. 2002) . Expression of caspase - 8L was found in many tissues and peripheral blood  lymphocytes  (Himeji,  Horiuchi  et  al.  2002)   and  prevents  CD34 +   hematopoietic  progenitor  cells  from  CD95   receptor - mediated   apoptosis   (Mohr,  Zwacka  et  al.  2005) .In a first approach, we analyzed caspase - 8 expression in EPC on mRNA and  protein  level  by  western  blot  analysis  and  confocal  imaging.  Additionally,  we  compared  Caspase - 8  mRNA  l evels  in  different  cell  types  (Fig.3.2.1a,b,c).  Our  analysis by RT - PCR revealed that caspase - 8L is expressed only in freshly isolated  mononuclear cells compared to very low level in day 3 suspension cells and adherent  day 3 EPC. In contrast, HUVEC did not  express caspase - 8L (Fi.3.2.1.a lower panel).  These results let assume that caspase - 8L as an inhibitor of apoptosis induction is  only expressed in hematopoietic cells. Perhaps, transcription of this splice variant is  repressed  during  cell  differentiation.  F urthermore,  caspase - 8  is  generally  less 4. Discussion     57     transcribed  in  HUVEC  compared  to  monocytes,  CD34 +   and  EPC  (Fig.3.2.1c).  Caspase - 8  as  an  initiator  of  apoptosis  assumes  a  localization  in  the  cytoplasm  triggered by outside - in - signaling close to the cell membrane.  How ever,  we  detect ed   caspase - 8 in  the cytoplasm as well as in  the nucleus  by confocal images  (Fig.3.2.1b).  This  observation  was  already  described  by  Besnault - Mascard  et  al.   They   found  nuclear  localization  of  caspase - 8  associated  with  sumoylation  in  the  N - term inal  DEDs. The localization of the nuclear p75 (75kDa) caspase - 8 was controlled by a  SUMO - 1 - dependent pathway, whereas non - sumoylated p50 - 55 caspase - 8 forms are  present in the cytoplasm  (Besnault - Mascard, Leprince et  al. 2005) . In our study, the  non - sumoylated  p50 - 55  active  form  of  caspase - 8  in  the  cytoplasm  is  part  of  our  investigations where direct and close interaction to cytoplasmic signaling proteins are  important.       4.4   Non - apoptotic function of Caspase - 8   Caspase - 8 as an initiator of programmed cell death induction activates executioner  caspase - 3 by cleavage  (Cohen 1997) ,  which cleaves  other  downstream targets to  switch  on  the  apoptosis  machinery.  Measurements  of  caspase - 8  and  - 3  activity  showed  that  high  caspase - 8  activity  in  EPC  compared  to  periphera l  blood  mononuclear cells and to adherent cells at day 3 of culture did not increase caspase - 3 activity (Fig.3.5.1a,b). In this case, activity of caspase - 8 does not induce apoptosis  as shown by measuring apoptotic cells with Annexin V (Fig.3.5.2). In accor dance,   other results indicates  that caspase - 3 is, beside apoptotic signaling,  also involved in  other cellular processes like embryonic stem cell differentiation  (Fujita, Crane et al.  2008)  and alters the sensitivity to cytokine stimulation in hematopoi etic stem cells  (Janzen, Fleming et al. 2008) . However, mice with genetic gene deletion  of caspase - 3 are born alive without vascular defects  (Woo, Hakem et al. 2003) . Dernbach et al.  revealed that EPC are more resistant to oxidative stress and less sensitive to ROS  (reactive  oxygen  species) - induced  ap optosis  compared  to  other  cell  types.  They  express  higher  portions  of  catalase,  glutathione - peroxidase  and  manganese  superoxide dismutase than mature endothelial cells  (Dernbach, Urbich et al. 2004) . 4. Discussion     58     Higher levels of caspase - 8 and subsequent apoptosis induction might be blocked by  the  antioxidative  poss ibilities  of  EPC.  Additionally,  some  metastatic  tumor  cells  express active caspase - 8 which generates   programmed cell death  sensitivity  but is  also able to suppress metastasis  (H elfer, Boswell et al. 2006) . Caspase - 8 inhibition in  EPC could influence a similar process like in metastatic tumor cells by disturbing  integrin - mediated  attachment  signaling.  Concluding  from  our  caspase - 3  results,  caspase - 8  may  act  directly  rather  than  t hrough  caspase - 3  to  cleave  substrates  critical for cell motility although other effector caspases cannot be excluded  (Helfer,  Boswell et al. 2006) .     4.5   Cell adhesion and migration  in the presence of caspase - 8 inhibitor is due  to transmembrane molecule reduction   Recent reports described a role of caspases in the control of sperm individualization,  cell  morphology  and  migration  (Lamkanfi,  Festjens  et  al.  2007)   (Li,  Brieher  et  al.  2007) . Furthermore, a dhesion and migration  ability of different cells  are importan t  features  for  vascularization  in  new  growing  vessels.  Since  caspase - 8  inhibition  blocked  the  formation  of  fibronectin - adherent  EPC,  we  questioned  weather  EPC  adhesion  in  response  to  caspase - 8  is  specific  for  fibronectin.   Dysregulation  of  integrin  α 5 is known to be essential for embryonic vessel formation as demonstrated  by vascular defects in integrin  α 5 - deficient mice  (Yang, Raybu rn et al. 1993) .  In order  to solve this question we performed adhesion assay using different matrices such as  recombinant  fibronectin,  ICAM - 1  and  collagen   I.  Adhesion  to  all  matrices  was  completely abolished, when the EPC were pretreated  with caspase - 8 in hibitor zIETD  and then replated (Fig.3.3.1) . This observation  exclud ed  the specificity of caspase - 8  inhibition to  α 5 β 1 - integrin, the specific receptor of fibronectin.   The adhesion to ICAM - 1 via ß2 - integrins was blocked to a similar extent.  Since the observ ed effect was not  specific for fibronectin, we could conclude  that adhesion is not only dependent on  integrin  α 5.     In  contrast  to  our  results,  p harmacological  inhibition of  caspase - 8  in  breast epithelial cells (MFC10A) did not influence adhesion  (Finlay and Vuori 2007)   demonstrating  specific  function  of  caspase - 8   in  EPC s.   Additionally ,   in  our  hands  4. Discussion     59     migration was block ed by caspase - 8 inhibitor in EPC s  independent of application of  the chemokines SDF - 1, VEGF and IL - 8, which are known to stimulate migration by  attracting  cells  (Fig.3.3.2a,b,c).  These  findings  might  be  well  explained  by  the  reduced surface expression of va rious integrins  like  α 5,  β 1,  αvβ3 ,  CD11a   (3.8.1a - c)  and the chemokine receptor CXCR4 (3.8.2a) .   The integrin subunit  α 5 , however, was  most  efficiently  downregulated  by  treatment  of  EPCs  with  zIETD  (Fig.3.8.1a).  Furthermore,  we already know that  ß2 - integrins  are important for EPC adhesion and  transmigration  (Chavakis, Aicher et al. 2005) .  Moreover, integrin  α 5 was reduced in  whole cell protein lysates, FACS analysis and fluorescence staining. In contrast,  β 1  and  β 2 int egrins were not regulated on protein level. Since regulation of  β 1 and  β 2  integrins on protein level are missing, caspase - 8 inhibition might additionally block  adhesion  by  interfering  with  intracellular  signaling.  CXCR4  is  a  transmembrane  receptor  expresse d  by  peripheral  blood  lymphocytes,   monocytes,  thymocytes,  dendritic  cells   and  endothelial   cells   which  is  critical  in  embryonic  vascularization.   Caspase - 8 inhibition by zIETD significantly reduced the chemokine receptor CXCR4  (3.8.2a)   and  lead  to  the  ineffe ctive  attraction  by  its  ligand  SDF - 1  (3.3.2a) .  The  CXCR4  receptor  is  important  for  the  proangiogenic  potential  of  EPCs  (Zemani,  Silvestre et al. 2008) .   In  addition, the expression of the endothelial marker protein  V EGF - receptor 2 (KDR) was slightly decreased by about 20% after addition of the  caspase - 8 inhibitor. Interestingly, HUVEC and HMVEC migration was not affected by  different caspase inhibitiors. This lack of response might be explained by the low  caspase - 8 mR NA expression in these mature endothelial cells.  The results indicate  that caspase - 8 activity controls integrins and chemokine - receptors involved in matrix  adhesion  and  migration  of  EPC.  Unfortunately,  since  we  were  not  successful  in  transducing EPC with l entiviral vectors provided, we were unable to perform rescue  experiments by overexpression of integrin  α 5,  β 1 and CXCR4 simultanously to the  inhibition of caspase - 8. In summary we demonstrated that inhibition of Caspase - 8  impairs  migration  and  adhesion  of  circulating  blood  or  bone  marrow - derived  hematopoietic cells. Because of the low Caspase - 8 expression, mature endothelial  cells are not affected by Caspase - 8 inhibitors.  However, caspase - 8 is not the only  caspase involved in the adhesion and migration mac hinery. Caspase - 11 has been 4. Discussion     60     also  shown  to  be  involved  in  cytoskeleton  organization  by  mediating  depolymerization  in lymphocytes   (Li, Brieher et al. 2007) .      4.6   Growth factor production is influenced indirectly by caspa se - 8    Since EPC derive from hematopoietic precursors, one may argue that inhibition of  EPC  proliferation  or  differentiation  or  alternatively  an  influence  on  cytokine  expression caused the abrogation of adherent EPC by caspase - 8 inhibition. Indeed,  caspase - 8 inhibitor treatment modulated the release of cytokines in vitro. Thus, the  release of SDF - 1 and HGF was significantly reduced whereas IGF - 1 was slightly but  not significantly increased. However, the profound and rapid effects of the caspase - 8  inhibitor  o n  cell  adhesion  and  on  α 5 β 1 - expression  are  unlikely  caused  by  an  inhibition of differentiation or modulation of cytokine levels. Most likely, the effects on  differentiation and on cytokine levels are secondary to the impaired interaction of  α 5 β 1 - integrin t o fibronectin and the reduced number of cytokine - producing adherent  cells after caspase - 8 inhibition.      4.7   Caspase - 8 inhibition in EPC impedes neovascularization   Tissue neovascularization in hind limb ischemia or myocardial infarction is enhanced  by transplan ted endothelial precursor cells  (Kalka, Masuda et al. 2000)   (Kawamoto,  Gwon  et  al.  2001) .  In  accordance  to  previous  results  from  our  group  and  other  investigators, the transplantation of EPC into athymic nude mice  increased blood flow  recovery  and prevented limb  necrosis  by incorporation of EPC into the ischemic area  (Urbich and Dimmeler 2004) . By contrast, pretreatment of EPC with ph armacological  caspase - 8 inhibitors reduced incorporation of cells in the ischemic tissue as well as  perfusion and blood flow recovery of the ischemic limb (Fig. 3.6.1a,b and 3.6.2). In  order to analyze caspase - 8 deficiency without the use of pharmacologica l inhibitors,  we used bone marrow cells from conditional caspase - 8 knockout mice induced by  the  interferon - responsive  Mx1  promoter.  Similar  to  pharmacological  inhibition  by 4. Discussion     61     zIETD,  isolated  and  cultured  mouse  EPC   from  spleen   lacking  caspase - 8  had  reduced ab ilities to form fibronectin - adherent cells compared with wildtype cells  in  vitro .  Because  EPCs come from the bone marrow and float in the circulatory system ,   m ouse EPCs can be  easily  isolated from the bone marrow. EPC are separated by  ficoll  density  centri fugation.   B lood  flow  recovery  and  capillary  density  in  the  hind  limbs after ischemia were reduced in samples with intravenously injected caspase - 8 - deficient BMC cells  (Fig. 3.7.4) . This requirement of caspase - 8 for progenitor cell - mediated postnatal neovas cularization extends previous findings demonstrating an  essential role of this specific caspase for the development of the mouse embryonic  yolk sac vasculature and circulation  (Kang, Ben - Moshe et al. 2004) .  Addition ally to  integrin  α 5 downregulation in caspase - 8 deficient BMCs, integrin  α 4 null mice have  defects in placental and cardiac development resulting as well in embryonic lethality  (Yang,  Rayburn  et  al.  1995)   and  may  contribute  to  defective  embryonic  vessel  formation  in  caspase - 8 - deficient  mice.  Accordingly  to  our  previous  results  using  pharmacological  inhibitors  for  Caspase - 8,  homing  proteins  like  integrin  alpha5,  alpha4  and  CXCR4  receptor  were  significantly  reduced  in  conditional  caspase - 8  knockout  BMCs  (Fig.3.7.6a,b,d) .  These  results  support  once  again  a  novel  apoptosis - unrelated  role  of  caspase - 8  for  endothelial  precursor  cells  in  a  cell - autonomous fashion. Our  in vivo  data using caspase - 8 deficient cells underline the  adhesion  and  migration  disturbance  as  well  as  the  limited  homing  and  neovascularization capacity of cultured zIETD - treated human EPC. Thus , th is  study  discloses an apoptosis - unrelated mechanism by which caspase - 8 signaling interferes  with angiogenic cell processes mediated by progenitor cell administratio n.     4.8   Cbl - b is a novel target of caspase - 8   The  question  remained  how  caspase - 8  regulates  the  fibronectin  receptor   integrin  α 5 β 1  and CXCR4. We tried to further identify the mechanisms, by which caspase - 8  activity  contributes  to  preservation  of  the  fibronectin   α 5 β 1  and  CXCR4  receptor  surface  expression  and  interferes  with  integrin  and  cytokine  signaling .  It   is   conceivable  tha t   caspase - 8  continuously  degrades  inhibitors  of  integrins  and 4. Discussion     62     chemokine signaling such as ubiquitin - ligases  like Cbl - b  or regulators of the family of  small GTPases. Three mammalian homologue proteins are characte rized of the Cbl - family:  c - Cbl,  Cbl - b  and  Cbl - c.  They   are  ubiquitin  ligases  and   act  as  negative  regulators of signaling responses with receptor tyrosine kinases, phosphatases,  other  ubiquitin  ligases  and  adaptor  proteins  to  influence  cell  proliferation,  su rvival  and  migration. Cbl recruit ubiquitin - carrier enzymes or ubiquitin - conjugating enzymes as  well as direct the multi - ubiquitination of various proteins and promote their sorting for  lysosomal  degradation  (reviewed  in  (Schmidt  and  Dikic  2005) ).  Based  on  the  publication  of  Cbl - m ediated  ubiquitination  of  the  integrin  α 5  subunit  in  calvarial  osteoblasts  (Kaabeche,  Guenou  et  al.  2005) ,  we  analyzed  the  expression  of  the  major Cbl proteins involved in T - cell receptor signaling  (Thien and Langdon 2005) .  Interestingly, c - Cbl is highly expressed in CD34 +  cells, contrary to high levels of Cbl - b  in EPC. Howev er, both ubiqutin ligases are expressed at low level in HUVEC and  monocytes. This cell or tissue distributions may reflect the different phenotypes in  mice depleted of c - Cbl and Cbl - b  (Naramura, Jang et al. 2002) . Interestingly, also  bone  marrow - derived  IgE - activated  mast  cells  express  high  l evels  of  Cbl - b  while  deficiency  leads  to  cell  growth  and  retardation  in  receptor  internalization  (Gustin,  Thien et al. 2006) . Indeed, the present study provides experimental evidence that  Cbl - b is a target of caspas e - 8. Several in vitro experiments indicate that caspase - 8  cleaves  the  molecular  adaptor  protein   Cbl - b  using  different  truncated  constructs  (Fig.3.9.7). Inhibition by zIETD leads to downregulation of integrin  α 5 protein and  β 1  cell surface reduction in EPC.  In contrast, pharmacological zIETD treatment results in  Cbl - b upregulation (Fig.3.9.2). These data are consistent with the reduction in  α 5  integrin  expression  after  caspase - 8  inhibition  shown  by  western  blot  and  fluorescence  images.  The  fibronectin  recept or  subunit  integrin  α 5  was  previously  shown  to  be  regulated  by  post - transcriptional  modification  coupled  to  proteasome  degradation directly by Cbl - b  in  osteoblasts  (Kaabeche, Guenou et al. 2005) . We  assumed that  α 5  is a multiubiquitiylated target protein for degradation  (Ciechanover  2005)   whereas  integrin  β 1  is  only  monoubiquitiylated  to  recruit  other  signaling  proteins  (Hicke 2001) . Therefore, provided by experimental evidence that caspase - 8  cleaves the molecular adaptor protein Cbl - b, we assume that the interaction between 4. Discussion     63     Cbl - b  and  integrin  α 5   might  contribute  to  the  inhibitory  effects  shown  in  in  vitro   adhesion and migration as well as  in vivo  neovascularization capacity of caspase - 8 - deficient bone marrow cells and leading to interference with intracellular signaling by  blocking functional i ntegrin signaling.                                  Figure 4.8.1 : Caspase - 8 is involved in proper  EPC  function    This schematic illustration reflects our results  and opinion   about  caspase - 8 function in EPC.  Even  w e  can  not  exclude  the  inv olvement  of  other  signalling  proteins  so  far ,  we  demonstrated  that  Cbl - b  is  a  target  of  caspase - 8 .   Adhesion  and  migration  proteins  like  integrins and CXCR4 are regulated in this signalling process dependent on the protein levels  of  caspase - 8  and  Cbl - b.   Neo vascularization  is  inhibited  after  caspase - 8  inhibition/gene  deletion and is increased after Cbl - b gene deletion.       4.9   Cbl - b inhibition promotes angiogenesis in vitro and in vivo   To demonstrate the role of Cbl - b in angiogenesis, we used Cbl - b - deficient BMCs  for  in vivo assays. Interestingly, these  BMCs showed higher levels in integrin α5, CXCR4  and VEGF - R2 (KDR)  (data not shown) .  Furthermore, Cbl family members function as 4. Discussion     64     adaptor proteins downstream of CXCR4 by forming multiprotein signaling complexes  in response to SDF - 1 α  in outside - in signaling  (Chernock, Cherla et al. 2001) . Our  findings  in  receptor surface  reduction  after caspase - 8 inhibition in EPC and caspase - 8 - deficie nt bone marrow cells support our opinion about a regulating link between  caspase - 8 an d Cbl - b which was observed in  increased  angiogenesis in matrigel and  neovascularization  assays  by  Cbl - b - deficient  bone  marrow  cells.  Controversially,  recent publication demonstrates that Cbl - b - deficient bone marrow - derived mast cells  produce significant hi gher levels of inflammatory cytokines TNF - α , IL - 6 and MCP - 1  compared to wildtype and c - Cbl - / -  cells  (Gustin, Thien et al. 2006) .  Probably, bone  marrow  derived  cells  from  Cbl - b - / -   mice  act  in  a  similar  way  by  stimu lating  and  positively  supporting  vessel  growth  with  enhanced  adhesion  and  increased  chemokine  receptors   expression .   Furthermore,  the  negative  regulation  of  angiogenesis by Cbl - b was confirmed by siRNA downregulation in endothelial cells  resulting  in  functi onal  disturbance  of  sprouting  activity  and  migration  capacity  (Fig.3.10.2  and  3.10.3).  Cbl - b  inhibition  by  siRNA  significantly  increased  sprout  length and migration activity in endothelial cells demonstrating a similar importance  like in EPC. As recently p ublished caspase - 8 interacts with Src tyrosine kinase to  promote adhesion  (Finlay and Vuori 2007) . Interestingly,  Src and Cbl - b are important  for  activation  of  integrins  and  actin - associated  proteins  in  osteoclast  function  and  differentiation  (Horne, Sanjay et al. 2005)  supporting our results of positive caspase - 8 downstream signaling in EPC. Additionally, Cbl - b promotes the ubiquitination of  phosphat idylinositol  3 - kinase  (PI3K)  (Fang,  Wang  et  al.  2001) .  Inhibition  of  PI3K  reduces  chemokine - induced  migration  and  adhesion  of  progenitor  cells  via  β 2 -   integrins and impedes neovascularization of ischemic tissue  (Chavakis, Carmona et  al. 2008) . Furthermore, it was shown that  c - Cbl ubiquitin ligase negatively regulates  the small GTPase Rap1 activation   (Shao, Elly et al. 2003)  important for cell adhesion  via integrin regulation  (Bos 2005)  and cell - cell fun ction formation  (Kooistra, Dube et  al. 2007) . However, despite the obvious relevance of a proper regulation of adhesion  molecules for the retention of circulatin g precursor cells to target tissues, a role of  Cbl - b for neovascularization - promoting progenitor cell function is not known.   4. Discussion     65     Besides Cbl - b, caspase - 8 could promote adhesion, migration and neovascularization  in  EPC  in  vivo  through  other  putative  targets.  A dditionally,  Caspase - 8  promotes  calpain activity which is implicated in adhesion, lamellipodial movement cycles and  activation  of  rac  important  for  cytoskeleton  remodeling  (Franco  and  Huttenlocher  2005) .    High  expression  of  Calpain  was  detected  in  our  microarray  data  in EPC,  HUVEC  and  monocytes  but  not  in  hematopoietic  CD34 +   cells  (data  not  shown).  Recently, Senft et a l. found that phosphorylated caspase - 8 interacts with the p85  subunit of Phosphatidylinositol 3 - kinase  (Senft, Helfer et al. 2007) . Interestingly, as  mentioned before, Cbl - b can also bind the p85 subunit of P I3K   (Fang, Wang et a l.  2001) . Caspase - 8 and Cbl - b may possibly compete with each other under specific  conditions.  Furthermore,  other  possible  targets  affecting  integrin  function  include  kindlins,  which  are  indispensable  for  cytoskeleton  organization  and  function,  cell - matrix  adhesion  (Larjava, Plow et al. 2008)  and bidirectional signaling via integrins  (Montanez,  Ussar  et  al.  2008)   and  can  inhibit  integrin - dependent  adhesion  and  migration. But possible regulation by non - apoptotic caspase - 8 activation has  to be  investigated so far.        4.10   Non - apoptotic caspase - 8 regulation in EPC   After demonstrating a novel non - apoptotic role of Caspase - 8 in EPC incorporation,  we  questioned  what  might  regulate  caspase - 8  expression  in  an  apoptosis - independent way. The limited ca spase - 8 activation  may  occur independent of pro - apoptotic TNF or Fas receptor stimulation  because no apoptosis  was induced  in the  cells.   As previously shown, caspase - 8 can  interact with the long isoform of cellular  Flice - like inhibitory protein (cFlip L ) (r eviewed in  (Budd, Yeh et al. 2006) ), which allows  for  selective  degradation  of  substrates  within  a  close  local  subcompartiment  (Lamkanfi, Festjens et al. 2007) .  This means in close distance to the cell membrane  where different complexes are built up besides the DISC (Death - inducing signalling  complex).   Recently,  Sun  et  al.  iden tified  a  novel  antiapoptotic  protein  complex  containing glycogen synthase kinase - 3, DDX3 and cellular inhibitory protein - 1 which  inhibits  apoptotic  caspase - 8  activation  by  impeding  DISC  formation.  The  detailed 4. Discussion     66     protein complex coordination is still unknown  (Sun, Song et al. 2008)  but could be an  explanation for upstream non - apopt otic caspase - 8 regulation in EPC.  Understanding  the signals involved in the regulation of low grade caspase - 8 activity and caspase - 8  mRNA processing may identify upstream mechanisms of the caspase - 8 - dependent  vasculogenic progenitor cell function. Addition ally, besides intracellular signaling by  protein  complex  formation,  attraction  of  EPC  to  ischemic  tissue  could  be  another  caspase - 8 regulating process. TGF - β1 , TNF - α , IL - 1, IL - 6 and IL - 8 were localized in  myocardial  ischemic  tissue  and  involved  in  inflamma tory  processes  (reviewed  in  (Sharma and Das 1997) ). Interestingly, exposure to the pro - inflammatory cytokine IL - 6 increased vascular expression of  α 5 and  β 4 integrin subunits of astrocytes in the  central nervous system  (Milner an d Campbell 2006) . Additionally, interleukin - 6 act as  an  angiogenic  factor  and  mediates  proliferation  and  migration  of  endothelial  cells  (Yao,   Zhai  et  al.  2006) .  Furthermore,  IL - 6  enhances  migration,  development  and  repopulation of human stem cells by increasing CXCR4 surface expression  (Lapidot  2001) .  Recent  publication  suggests  that  blood - derived  EPC  are  recruited  by  IL - 6  caused by ischemic or inflammatory areas  (Fan, Ye et al. 2008) . In contrast to TNF - α  (data  not  shown) ,  IL - 6  incr eased  the  number  of  fibronectin - adherent  endothelial  precursor cells from human peripheral blood. Based on these results, we analyzed  protein expression of Cbl - b and integrin  α 5 subunit surface expression. We found  decreased  Cbl - b  protein  levels  after  incr easing  IL - 6  concentration.  Interestingly,  integrin alpha5 surface expression was increased with IL - 6 stimulation. These results  indicate that cytokine stimulation could positively influence EPC recruitment showing  in  Cbl - b  and  integrin  α 5  change.  However,  causal  relevance of caspase - 8  in  this  process could not be proved by a rescue experiment.   5. Conclusion     67     5.   Conclusion   Vasculogenesis as well as angiogenesis are important for postnatal development of  blood vessels.  P eripheral blood or bone marrow - derived endothelial prec ursor cells  are used in clinical trials for therapeutic enhancement of postnatal neovascularization  in patients suffering from coronary artery diseases.  T he vasculogenic potential of the  precursor  cell  population  depends on  the  appropriate retention of the  infused cells to  the ischemic tissue.  However, cell - autonomous mechanisms regulating the attraction  and  retention  of  circulating  cells  in  inflammatory  tissue  are  not  well  understood.  Caspases belong to a family of pro - apoptotic enzymes. Beyond cell death  signals,  caspase  proteases  additionally  regulate  non - apoptotic  processes  like  cell  morphology a nd migration in many cell types.   The  isoform  Caspase - 8  is   essential  for  embryo nal  vasculogenesis  in  conditional  knockout  mice .  In  this  study ,  we  identified  a  nov el  apoptosis - unrelated  role  of  Caspase - 8  in circulating and bone marrow - derived cells for vascular repair.  Caspase - 8 - specific inhibition abrogated the  ex vivo  formation of EPC from human peripheral  blood.  Moreover,  Caspase - 8  inhibition   disables  EPC  migrati on  and  adhesion  to  different  matrices  and   decrease s  the   cell  surface  expression   of  the   fibronectin  receptor subunit integrin α5  and the chemokine receptor CXCR4 .   In vitro  and  in vivo   studies  using   bone  marrow  mononuclear  cells   derived  from  inducible   Caspase - 8 - deficient  mice  revealed  an  essential   role  of  Caspase - 8  for  EPC  formation   and  neova scularization   enhancing  capacities  of  progenitor  cells .   Caspase - 8  activity  appears  to  be  required  for  maintaining  responses  to  matrix  interaction  and  chemoattractants of EPC.    Additional  studies showed that the E3 ubiquitin ligase Cbl - b, a negative regulat or of  cell adhesion molecules  including   integrin  α5, is  present in   EPC at low protein levels  under basal condition s,   but   markedly  increases  upon  Caspase - 8  inhibition .   In vitro   assays and overexpression  studies  in intact cells confirmed  Caspase - 8 - dependent  degradation   of  Cbl - b ,  providing  a   potential  requ irement  for  Caspase - 8 - regulated  adhesion .   In deed,  neovascularization  of  matrigel plug s  was enhanced in mice lacking  Cbl - b.   Moreover,   Cbl - b  degradation in the presence of  active Caspase - 8  prevents  the 5. Conclusion     68     down - regulation  of  integrin  α5   and  is  associated  with  an   enhanced  vasculogenic  activity of  progenitor cells in hind limb ischemia. The identified upstream regulation of  caspase - 8 by cytokine IL - 6 is only one possibility for fine - tuning the non - apoptotic  enzymatic activity.   In summary,   this study shows a novel e ssential role of  Caspase - 8  for proper EPC  adhesion - related  signaling.  Caspase - 8  is  involved  in  the  function  of  adhesion  molecules by regulation the E3 ubiquitin ligase Cbl - b.  Strategies to improve survival  of  therapeutic  injected  progenitor  cells  by  using   caspase  inhibitors  should  be  addressed  with  caution.  Because  of  the  broad  spectrum  of  activity  of  caspase - 8,  downstream targets of this caspase isoform and Cbl - b should be in more focus for  therapeutic pretreatment to improve neovascularization of myocard ial and ischemic  tissue.             6. Abbreviations     69     6.   Abbreviations   Ac - LDL   acetylated   low - density lipoprotein   Bp   Base pairs   BSA   Bovine serum albumin   CAD   Coronary artery disease   cDNA   complementary DNA   Ct   C - terminus   DAPI   4`,6 - diamidino - 2 - phenylindole   DISC   Death - inducing sig naling complex   DNA   Desoxyribonucleic acid   DTT   Dithiothreitol   e.g.   for example   EC   Endothelial cells   ECM   Extracellular matrix   EDTA   Ethylendiamintetra acetic acid    eNOS   Endothelial nitric oxide  synthase   EPC   Endothelial precursor (progenitor) cell   et  al.    and others   FACS   Fluorescence - activated cell sorting   FCS   Fetal calf serum   Fig.   Figure   FITC   Fluorescein isothiocyanate   Flip   Flice - like inhibitory protein   g   grams or g force   GAPDH   Glycerinaldehyd - 3 - Phosphat - Dehydrogenase    6. Abbreviations     70     h   hour(s)   HEK293   Human e mbryonal kidney epithelial cells   HMVEC   Human microvascular endothelial cells   HUVEC   Human umbilical vein endothelial cells   i.v.    intra venous   kDa   Kilodalton   KDR   VEGF receptor 2   min   minutes   MNC   Mononuclear cells   m RNA   Messenger ribonucleic  acid   n   Num ber of experiements   n.s.   Not significant   Nt   N - terminus   OD    Optical density   PBS   Phosphate buffered saline   PIGF   Placenta growth factor   PMSF   Phenylmethylsulfonylfluorid   RT   Room temperature  or reverse  transcription   SDS   Sodium - dodecyl - sulfate   SEM   Stand ard error of the mean   siRNA   Small interfering RNA   TNFα   Tumor necrotic factor alpha   VEGF   Vascular endothelial growth factor   VEGF   Vascular endothelial growth factor   vWF   Von - Willebrand factor   Wt   wildtype    7. Bibliography     71     7.   Bibliography     Aicher, A., C . Heeschen, et al.  (2003). "Essential role of endothelial nitric  oxide synthase for mobilization of stem and progenitor cells."  Nat  Med   9 (11): 1370 - 6.   Arama,  E.,  J.  Agapite,  et  al.  (2003).  "Caspase  activity  and  a  specific  cytochrome C are required for sper m differentiation in Drosophila."  Dev Cell   4 (5): 687 - 97.   Asahara, T., T. Murohara, et al. (1997). "Isolation of putative progenitor  endothelial cells for angiogenesis."  Science   275 (5302): 964 - 7.   Assmus, B., V. Schachinger, et al. (2002). "Transplantation o f Progenitor  Cells  and  Regeneration  Enhancement  in  Acute  Myocardial  Infarction (TOPCARE - AMI)."  Circulation   106 (24): 3009 - 17.   Bachmaier,  K.,  C.  Krawczyk,  et  al.  (2000).  "Negative  regulation  of  lymphocyte activation and autoimmunity by the molecular adaptor  Cbl - b."  Nature   403 (6766): 211 - 6.   Bader,  B.  L.,  H.  Rayburn,  et  al.  (1998).  "Extensive  vasculogenesis,  angiogenesis, and organogenesis precede lethality in mice lacking  all alpha v integrins."  Cell   95 (4): 507 - 19.   Besnault - Mascard, L., C. Leprince, et al. (20 05). "Caspase - 8 sumoylation  is associated with nuclear localization."  Oncogene   24 (20): 3268 - 73.   Boatright, K. M. and G. S. Salvesen (2003). "Mechanisms of caspase  activation."  Curr Opin Cell Biol   15 (6): 725 - 31.   Boldin, M. P., T. M. Goncharov, et al. (1996) . "Involvement of MACH, a  novel MORT1/FADD - interacting protease, in Fas/APO - 1 -  and TNF  receptor - induced cell death."  Cell   85 (6): 803 - 15.   Bos,  J.  L.  (2005). "Linking Rap to  cell  adhesion."  Curr Opin Cell  Biol   17 (2): 123 - 8.   Budd, R. C., W. C. Yeh, et al. (20 06). "cFLIP regulation of lymphocyte  activation and development."  Nat Rev Immunol   6 (3): 196 - 204.   Carmeliet, P. (2000). "Mechanisms of angiogenesis and arteriogenesis."  Nat Med   6 (4): 389 - 95.    7. Bibliography     72     Carmeliet,  P.  (2003).  "Angiogenesis  in  health  and  disease."  Nat  Me d   9 (6): 653 - 60.   Carmeliet,  P.  (2005).  "Angiogenesis  in  life,  disease  and  medicine."  Nature   438 (7070): 932 - 6.   Carmeliet,  P.,  V.  Ferreira,  et  al.  (1996).  "Abnormal  blood  vessel  development  and  lethality  in  embryos  lacking  a  single  VEGF  allele."  Nature   380 (65 73): 435 - 9.   Chavakis, E., A. Aicher, et al. (2005). "Role of beta2 - integrins for homing  and neovascularization capacity of endothelial progenitor cells."  J  Exp Med   201 (1): 63 - 72.   Chavakis, E., G. Carmona, et al. (2008). "Phosphatidylinositol - 3 - kinase - gamma  is integral to homing functions of progenitor cells."  Circ Res   102 (8): 942 - 9.   Chernock, R. D., R. P. Cherla, et al. (2001). "SHP2 and cbl participate in  alpha - chemokine receptor CXCR4 - mediated signaling pathways."  Blood   97 (3): 608 - 15.   Chiang,  Y.  J.,  H.  K.   Kole,  et  al.  (2000).  "Cbl - b  regulates  the  CD28  dependence of T - cell activation."  Nature   403 (6766): 216 - 20.   Choi,  K.,  M.  Kennedy,  et  al.  (1998).  "A  common  precursor  for  hematopoietic and endothelial cells."  Development   125 (4): 725 - 32.   Chun, H. J., L. Zheng , et al. (2002). "Pleiotropic defects in lymphocyte  activation  caused  by  caspase - 8  mutations  lead  to  human  immunodeficiency."  Nature   419 (6905): 395 - 9.   Ciechanover, A. (2005). "Proteolysis: from the lysosome to ubiquitin and  the proteasome."  Nat Rev Mol Cel l Biol   6 (1): 79 - 87.   Cohen,  G.  M.  (1997).  "Caspases:  the  executioners  of  apoptosis."  Biochem J   326 : 1 - 16.   De  Botton,  S.,  S.  Sabri,  et  al.  (2002).  "Platelet  formation  is  the  consequence of caspase activation within megakaryocytes."  Blood   100 (4): 1310 - 7.   De  C lercq,  E.  (2005).  "Potential  clinical  applications  of  the  CXCR4  antagonist bicyclam AMD3100."  Mini Rev Med Chem   5 (9): 805 - 24.    7. Bibliography     73     Dernbach, E., C. Urbich, et al.  (2004). "Antioxidative stress - associated  genes  in  circulating  progenitor  cells:  evidence  for  enhan ced  resistance against oxidative stress."  Blood   104 (12): 3591 - 7.   Dimmeler, S., A. Aicher, et al. (2001). "HMG - CoA reductase inhibitors  (statins)  increase  endothelial  progenitor  cells  via  the  PI  3 - kinase/Akt pathway."  J Clin Invest   108 (3): 391 - 7.   Duarte, A. , M. Hirashima, et al. (2004). "Dosage - sensitive requirement  for mouse Dll4 in artery development."  Genes Dev   18 (20): 2474 - 8.   Eggermann,  J.,  S.  Kliche,  et  al.  (2003).  "Endothelial  progenitor  cell  culture  and  differentiation  in  vitro:  a  methodological  compa rison  using human umbilical cord blood."  Cardiovasc Res   58 (2): 478 - 86.   Fan, Y., J. Ye, et al. (2008). "Interleukin - 6 stimulates circulating blood - derived endothelial progenitor cell angiogenesis in vitro."  J Cereb  Blood Flow Metab   28 (1): 90 - 8.   Fang, D., H.  Y. Wang, et al. (2001). "Cbl - b, a RING - type E3 ubiquitin  ligase, targets phosphatidylinositol 3 - kinase for ubiquitination in T  cells."  J Biol Chem   276 (7): 4872 - 8.   Fassler,  R.  and  M.  Meyer  (1995).  "Consequences  of  lack  of  beta  1  integrin gene expression  in mice."  Genes Dev   9 (15): 1896 - 908.   Ferrara,  N.,  K.  Carver - Moore,  et  al.  (1996).  "Heterozygous  embryonic  lethality  induced  by  targeted  inactivation  of  the  VEGF  gene."  Nature   380 (6573): 439 - 42.   Finlay, D. and K. Vuori (2007). "Novel noncatalytic role for c aspase - 8 in  promoting  SRC - mediated  adhesion  and  Erk  signaling  in  neuroblastoma cells."  Cancer Res   67 (24): 11704 - 11.   Francis, S. E., K. L. Goh, et al. (2002). "Central roles of alpha5beta1  integrin and fibronectin in vascular development in mouse embryos  an d embryoid bodies."  Arterioscler Thromb Vasc Biol   22 (6): 927 - 33.   Franco,  S.  J.  and  A.  Huttenlocher  (2005).  "Regulating  cell  migration:  calpains make the cut."  J Cell Sci   118 (Pt 17): 3829 - 38.   Frisch, S. M. (2008). "Caspase - 8: fly or die."  Cancer Res   68 (12):  4491 - 3.   Fujita,  J.,  A.  M.  Crane,  et  al.  (2008).  "Caspase  activity  mediates  the  differentiation of embryonic stem cells."  Cell Stem Cell   2 (6): 595 - 601.    7. Bibliography     74     Gale, N. W. and G. D. Yancopoulos (1999). "Growth factors acting via  endothelial  cell - specific  receptor  tyrosine  kinases:  VEGFs,  angiopoietins, and ephrins in vascular development."  Genes Dev   13 (9): 1055 - 66.   Gehling,  U.  M.,  S.  Ergun,  et  al.  (2000).  "In  vitro  differentiation  of  endothelial  cells  from  AC133 - positive  progenitor  cells."  Blood   95 (10): 3106 - 12.   Ge isbrecht, E. R. and D. J. Montell (2004). "A role for Drosophila IAP1 - mediated caspase inhibition in Rac - dependent cell migration."  Cell   118 (1): 111 - 25.   Grutter,  M.  G.  (2000).  "Caspases:  key  players  in  programmed  cell  death."  Curr Opin Struct Biol   10 (6): 6 49 - 55.   Gulati, R., D. Jevremovic, et al. (2003). "Diverse origin and function of  cells with endothelial phenotype obtained from adult human blood."  Circ Res   93 (11): 1023 - 5.   Gustin, S. E., C. B. Thien, et al. (2006). "Cbl - b is a negative regulator of  inflam matory  cytokines  produced  by  IgE - activated  mast  cells."  J  Immunol   177 (9): 5980 - 9.   Heeschen,  C.,  A.  Aicher,  et  al.  (2003).  "Erythropoietin  is  a  potent  physiological stimulus for endothelial progenitor cell mobilization."  Blood   17 : 17.   Heil,  M.,  I.  Eitenmull er,  et  al.  (2006).  "Arteriogenesis  versus  angiogenesis: similarities and differences."  J Cell Mol Med   10 (1):  45 - 55.   Helfer, B., B. C. Boswell, et al. (2006). "Caspase - 8 promotes cell motility  and  calpain  activity  under  nonapoptotic  conditions."  Cancer  Res   66 (8): 4273 - 8.   Hicke, L. (2001). "Protein regulation by monoubiquitin."  Nat Rev Mol Cell  Biol   2 (3): 195 - 201.   Hill,  J.  M.,  G.  Zalos,  et  al.  (2003).  "Circulating  endothelial  progenitor  cells,  vascular  function,  and  cardiovascular  risk."  N  Engl  J  Med   348 (7):  593 - 600.   Himeji, D., T. Horiuchi, et al. (2002). "Characterization of caspase - 8L: a  novel  isoform  of  caspase - 8  that  behaves  as  an  inhibitor  of  the  caspase cascade."  Blood   99 (11): 4070 - 8.    7. Bibliography     75     Hirasaka,  K.,  S.  Kohno,  et  al.  (2007).  "Deficiency  of  Cbl - b  gene  enha nces  infiltration  and  activation  of  macrophages  in  adipose  tissue and causes peripheral insulin resistance in mice."  Diabetes   56 (10): 2511 - 22.   Hodivala - Dilke,  K.  M.,  K.  P.  McHugh,  et  al.  (1999).  "Beta3 - integrin - deficient mice are a model for Glanzmann thro mbasthenia showing  placental defects and reduced survival."  J Clin Invest   103 (2): 229 - 38.   Horiuchi, T., D. Himeji, et al. (2000). "Dominant expression of a novel  splice  variant  of  caspase - 8  in  human  peripheral  blood  lymphocytes."  Biochem Biophys Res Commun   272 (3): 877 - 81.   Horne, W. C., A. Sanjay, et al. (2005). "The role(s) of Src kinase and Cbl  proteins in the regulation of osteoclast differentiation and function."  Immunol Rev   208 : 106 - 25.   Hur,  J.,  C.  H.  Yoon,  et  al.  (2004).  "Characterization  of  two  types  of  endothelial  progenitor  cells  and  their  different  contributions  to  neovasculogenesis."  Arterioscler Thromb Vasc Biol   24 (2): 288 - 93.   Jain, R. K. (2003). "Molecular regulation of vessel maturation."  Nat Med   9 (6): 685 - 93.   Janzen,  V.,  H.  E.  Fleming,  et  al.  ( 2008).  "Hematopoietic  stem  cell  responsiveness to exogenous signals is limited by caspase - 3."  Cell  Stem Cell   2 (6): 584 - 94.   Kaabeche, K., H. Guenou, et al. (2005). "Cbl - mediated ubiquitination of  alpha5 integrin subunit mediates fibronectin - dependent osteob last  detachment and apoptosis induced by FGFR2 activation."  J Cell  Sci   118 (Pt 6): 1223 - 32.   Kalka, C., H. Masuda, et al. (2000). "Transplantation of ex vivo expanded  endothelial  progenitor  cells  for  therapeutic  neovascularization."  Proc Natl Acad Sci U S A   97 (7): 3422 - 7.   Kang,  T.  B.,  T.  Ben - Moshe,  et  al.  (2004).  "Caspase - 8  serves  both  apoptotic and nonapoptotic roles."  J Immunol   173 (5): 2976 - 84.   Kawamoto, A., H. C. Gwon, et al. (2001). "Therapeutic potential of ex  vivo  expanded  endothelial  progenitor  cells  f or  myocardial  ischemia."  Circulation   103 (5): 634 - 7.    7. Bibliography     76     Kawamoto, A. and D. W. Losordo (2008). "Endothelial progenitor cells for  cardiovascular regeneration."  Trends Cardiovasc Med   18 (1): 33 - 7.   Kischkel, F. C., S. Hellbardt, et al. (1995). "Cytotoxicity - depend ent APO - 1 (Fas/CD95) - associated proteins form a death - inducing signaling  complex (DISC) with the receptor."  Embo J   14 (22): 5579 - 88.   Kissel, C. K., R. Lehmann, et al. (2007). "Selective functional exhaustion  of hematopoietic progenitor cells in the bone mar row of patients  with postinfarction heart failure."  J Am Coll Cardiol   49 (24): 2341 - 9.   Kooistra, M. R., N. Dube, et al. (2007). "Rap1: a key regulator in cell - cell  junction formation."  J Cell Sci   120 (Pt 1): 17 - 22.   Krawczyk, C., K. Bachmaier, et al. (2000).  "Cbl - b is a negative regulator  of  receptor  clustering  and  raft  aggregation  in  T  cells."  Immunity   13 (4): 463 - 73.   Krebs, L. T., J. R. Shutter, et al. (2004). "Haploinsufficient lethality and  formation  of  arteriovenous  malformations  in  Notch  pathway  mutants."   Genes Dev   18 (20): 2469 - 73.   Kuhn, R., F. Schwenk, et al. (1995). "Inducible gene targeting in mice."  Science   269 (5229): 1427 - 9.   Kumar, S. and J. Doumanis (2000). "The fly caspases."  Cell Death Differ   7 (11): 1039 - 44.   Lamkanfi,  M.,  W.  Declercq,  et  al.  (2002) .  "Alice  in  caspase  land.  A  phylogenetic analysis of caspases from worm to man."  Cell Death  Differ   9 (4): 358 - 61.   Lamkanfi,  M.,  N.  Festjens,  et  al.  (2007).  "Caspases  in  cell  survival,  proliferation and differentiation."  Cell Death Differ   14 (1): 44 - 55.   Lapid ot,  T.  (2001).  "Mechanism  of  human  stem  cell  migration  and  repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role  of SDF - 1/CXCR4 interactions."  Ann N Y Acad Sci   938 : 83 - 95.   Larjava, H., E. F. Plow, et al. (2008). "Kindlins: essential regulators of  in tegrin  signalling  and  cell - matrix  adhesion."  EMBO  Rep   9 (12):  1203 - 8.   Launay,  S.,  O.  Hermine,  et  al.  (2005).  "Vital  functions  for  lethal  caspases."  Oncogene   24 (33): 5137 - 48.    7. Bibliography     77     Lavrik,  I.  N.,  A.  Golks,  et  al.  (2005).  "Caspases:  pharmacological  manipulation of  cell death."  J Clin Invest   115 (10): 2665 - 72.   Leulier, F., A. Rodriguez, et al. (2000). "The Drosophila caspase Dredd is  required  to  resist  gram - negative  bacterial  infection."  EMBO  Rep   1 (4): 353 - 8.   Li, J., W. M. Brieher, et al. (2007). "Caspase - 11 regulates  cell migration  by  promoting  Aip1 - Cofilin - mediated  actin  depolymerization."  Nat  Cell Biol   9 (3): 276 - 86.   Lin, Y., D. J. Weisdorf, et al. (2000). "Origins of circulating endothelial  cells and endothelial outgrowth from blood."  J Clin Invest   105 (1):  71 - 7.   Log es,  S.,  B.  Fehse,  et  al.  (2004).  "Identification  of  the  adult  human  hemangioblast."  Stem Cells Dev   13 (3): 229 - 42.   Lyden,  D.,  K.  Hattori,  et  al.  (2001).  "Impaired  recruitment  of  bone - marrow - derived  endothelial  and  hematopoietic  precursor  cells  blocks tumor  angiogenesis and growth."  Nat Med   7 (11): 1194 - 201.   Maelfait, J. and R. Beyaert (2008). "Non - apoptotic functions of caspase - 8."  Biochem Pharmacol .   Max, R., R. R. Gerritsen, et al. (1997). "Immunohistochemical analysis of  integrin alpha vbeta3 expression on  tumor - associated vessels of  human carcinomas."  Int J Cancer   71 (3): 320 - 4.   McCarty,  J.  H.,  A.  Lacy - Hulbert,  et  al.  (2005).  "Selective  ablation  of  alphav  integrins  in  the  central  nervous  system  leads  to  cerebral  hemorrhage, seizures, axonal degeneration and  premature death."  Development   132 (1): 165 - 76.   Milner, R. and I. L. Campbell (2006). "Increased expression of the beta4  and alpha5 integrin subunits in cerebral blood vessels of transgenic  mice chronically producing the pro - inflammatory cytokines IL - 6 or  IF N - alpha in the central nervous system."  Mol Cell Neurosci   33 (4):  429 - 40.   Mohr, A., R. M. Zwacka, et al. (2005). "Caspase - 8L expression protects  CD34+  hematopoietic  progenitor  cells  and  leukemic  cells  from  CD95 - mediated apoptosis."  Oncogene   24 (14): 2421 - 9.   Montanez,  E.,  S.  Ussar,  et  al.  (2008).  "Kindlin - 2  controls  bidirectional  signaling of integrins."  Genes Dev   22 (10): 1325 - 30.    7. Bibliography     78     Murohara, T., H. Ikeda, et al. (2000). "Transplanted cord blood - derived  endothelial precursor cells augment postnatal neovasculariz ation."  J Clin Invest   105 (11): 1527 - 36.   Naramura, M., I. K. Jang, et al. (2002). "c - Cbl and Cbl - b regulate T cell  responsiveness  by  promoting  ligand - induced  TCR  down - modulation."  Nat Immunol   3 (12): 1192 - 9.   Okuyama,  R.,  B.  C.  Nguyen,  et  al.  (2004).  "High  co mmitment  of  embryonic  keratinocytes  to  terminal  differentiation  through  a  Notch1 - caspase 3 regulatory mechanism."  Dev Cell   6 (4): 551 - 62.   Orlic, D., J. Kajstura, et al. (2001). "Mobilized bone marrow cells repair  the  infarcted  heart,  improving  function  and  survival."  Proc  Natl  Acad Sci U S A   98 (18): 10344 - 9.   Peichev, M., A. J. Naiyer, et al. (2000). "Expression of VEGFR - 2 and  AC133 by circulating human CD34(+) cells identifies a population  of functional endothelial precursors."  Blood   95 (3): 952 - 8.   Pellegrini , M., S. Bath, et al. (2005). "FADD and caspase - 8 are required  for cytokine - induced proliferation of hemopoietic progenitor cells."  Blood   106 (5): 1581 - 9.   Peter, M. E. and P. H. Krammer (2003). "The CD95(APO - 1/Fas) DISC  and beyond."  Cell Death Differ   10 (1):  26 - 35.   Petrache, I., K. Birukov, et al. (2003). "Caspase - dependent cleavage of  myosin  light  chain  kinase  (MLCK)  is  involved  in  TNF - alpha - mediated  bovine  pulmonary  endothelial  cell  apoptosis."  Faseb  J   17 (3): 407 - 16.   Priestley,  G.  V.,  T.  Ulyanova,  et  al.  (2 007).  "Sustained  alterations  in  biodistribution of stem/progenitor cells in Tie2Cre+ alpha4(f/f) mice  are hematopoietic cell autonomous."  Blood   109 (1): 109 - 11.   Qin, J., O. Vinogradova, et al. (2004). "Integrin bidirectional signaling: a  molecular view."  PL oS Biol   2 (6): e169.   Rafii,  S.  and  D.  Lyden  (2003).  "Therapeutic  stem  and  progenitor  cell  transplantation  for  organ  vascularization  and  regeneration."  Nat  Med   9 (6): 702 - 12.   Riedl,  S.  J.  and  G.  S.  Salvesen  (2007).  "The  apoptosome:  signalling  platform of cell  death."  Nat Rev Mol Cell Biol   8 (5): 405 - 13.    7. Bibliography     79     Salmena,  L.  and  R.  Hakem  (2005).  "Caspase - 8  deficiency  in  T  cells  leads to a lethal lymphoinfiltrative immune disorder."  J Exp Med   202 (6): 727 - 32.   Salmena, L., B. Lemmers, et al. (2003). "Essential role for casp ase 8 in  T - cell  homeostasis  and  T - cell - mediated  immunity."  Genes  Dev   17 (7): 883 - 95.   Sandri, M., V. Adams, et al. (2005). "Effects of exercise and ischemia on  mobilization  and  functional  activation  of  blood - derived  progenitor  cells in patients with ischemic  syndromes: results of 3 randomized  studies."  Circulation   111 (25): 3391 - 9.   Schachinger,  V.,  S.  Erbs,  et  al.  (2006).  "Intracoronary  bone  marrow - derived progenitor cells in acute myocardial infarction."  N Engl J  Med   355 (12): 1210 - 21.   Schmidt,  M.  H.  and  I.  Di kic  (2005).  "The  Cbl  interactome  and  its  functions."  Nat Rev Mol Cell Biol   6 (12): 907 - 18.   Sebbagh, M., C. Renvoize, et al. (2001). "Caspase - 3 - mediated cleavage  of ROCK I induces MLC phosphorylation and apoptotic membrane  blebbing."  Nat Cell Biol   3 (4): 346 - 52.   Seeger, F. H., T. Tonn, et al. (2007). "Cell isolation procedures matter: a  comparison  of  different  isolation  protocols  of  bone  marrow  mononuclear  cells  used  for  cell  therapy  in  patients  with  acute  myocardial infarction."  Eur Heart J   28 (6): 766 - 72.   Sen ft,  J.,  B.  Helfer,  et  al.  (2007).  "Caspase - 8  interacts  with  the  p85  subunit of phosphatidylinositol 3 - kinase to regulate cell adhesion  and motility."  Cancer Res   67 (24): 11505 - 9.   Shao, Y., C. Elly, et al. (2003). "Negative regulation of Rap1 activation by  t he Cbl E3 ubiquitin ligase."  EMBO Rep   4 (4): 425 - 31.   Sharma, H. S. and D. K. Das (1997). "Role of cytokines in myocardial  ischemia and reperfusion."  Mediators Inflamm   6 (3): 175 - 83.   Shi, Q., S. Rafii, et al. (1998). "Evidence for circulating bone marrow - deri ved endothelial cells."  Blood   92 (2): 362 - 7.   Sordet, O., C. Rebe, et al. (2002). "Specific involvement of caspases in  the differentiation of monocytes into macrophages."  Blood   100 (13):  4446 - 53.    7. Bibliography     80     Spring,  H.,  T.  Schuler,  et  al.  (2005).  "Chemokines  direct  endot helial  progenitors  into  tumor  neovessels."  Proc  Natl  Acad  Sci  U  S  A   102 (50): 18111 - 6.   Stegh, A. H., H. Herrmann, et al. (2000). "Identification of the cytolinker  plectin  as  a  major  early  in  vivo  substrate  for  caspase  8  during  CD95 -   and  tumor  necrosis  facto r  receptor - mediated  apoptosis."  Mol Cell Biol   20 (15): 5665 - 79.   Strehlow, K., N. Werner, et al. (2003). "Estrogen increases bone marrow - derived  endothelial  progenitor  cell  production  and  diminishes  neointima formation."  Circulation   107 (24): 3059 - 65.   Su,  H.,   N.  Bidere,  et  al.  (2005).  "Requirement  for  caspase - 8  in  NF - kappaB activation by antigen receptor."  Science   307 (5714): 1465 - 8.   Sun, M., L. Song, et al. (2008). "Identification of an antiapoptotic protein  complex at death receptors."  Cell Death Differ   15 (12 ): 1887 - 900.   Takahashi, T., C. Kalka, et al. (1999). "Ischemia -  and cytokine - induced  mobilization of bone marrow - derived endothelial progenitor cells for  neovascularization."  Nat Med   5 (4): 434 - 8.   Tanjore, H., E. M. Zeisberg, et al. (2008). "Beta1 integrin  expression on  endothelial  cells  is  required  for  angiogenesis  but  not  for  vasculogenesis."  Dev Dyn   237 (1): 75 - 82.   Tepper,  O.  M.,  R.  D.  Galiano,  et  al.  (2002).  "Human  endothelial  progenitor cells from type II diabetics exhibit impaired proliferation,  adhesio n,  and  incorporation  into  vascular  structures."  Circulation   106 (22): 2781 - 6.   Thien,  C.  B.  and  W.  Y.  Langdon  (2005).  "c - Cbl  and  Cbl - b  ubiquitin  ligases: substrate diversity and the negative regulation of signalling  responses."  Biochem J   391 (Pt 2): 153 - 66.   T hornberry, N. A. (1998). "Caspases: key mediators of apoptosis."  Chem  Biol   5 (5): R97 - 103.   Thornberry, N. A. and Y. Lazebnik (1998). "Caspases: enemies within."  Science   281 (5381): 1312 - 6.   Tinel, A. and J. Tschopp (2004). "The PIDDosome, a protein complex  im plicated  in  activation  of  caspase - 2  in  response  to  genotoxic  stress."  Science   304 (5672): 843 - 6.    7. Bibliography     81     Urbich,  C.  and  S.  Dimmeler  (2004).  "Endothelial  progenitor  cells  functional characterization."  Trends Cardiovasc Med   14 (8): 318 - 22.   Urbich, C., C. Heeschen, et  al. (2003). "Relevance of monocytic features  for neovascularization capacity of circulating endothelial progenitor  cells."  Circulation   108 (20): 2511 - 6.   Urbich,  C.,  C.  Heeschen,  et  al.  (2005).  "Cathepsin  L  is  required  for  endothelial  progenitor  cell - induced   neovascularization."  Nat  Med   11 (2): 206 - 13.   Varfolomeev, E. E., M. Schuchmann, et al. (1998). "Targeted disruption  of the mouse Caspase 8 gene ablates cell death induction by the  TNF  receptors,  Fas/Apo1,  and  DR3  and  is  lethal  prenatally."  Immunity   9 (2): 2 67 - 76.   Vasa,  M.,  S.  Fichtlscherer,  et  al.  (2001).  "Increase  in  circulating  endothelial progenitor cells by statin therapy in patients with stable  coronary artery disease."  Circulation   103 (24): 2885 - 90.   Vasa, M., S. Fichtlscherer, et al. (2001). "Number and  migratory activity  of  circulating  endothelial  progenitor  cells  inversely  correlate  with  risk factors for coronary artery disease."  Circ Res   89 (1): E1 - 7.   Walter, D. H., J. Haendeler, et al.  (2005). "Impaired CXCR4 Signaling  Contributes  to  the  Reduced  Neova scularization  Capacity  of  Endothelial Progenitor Cells From Patients With Coronary Artery  Disease."  Circ Res   97 (11): 1142 - 51.   Widmann, C., S. Gibson, et al. (1998). "Caspase - dependent cleavage of  signaling proteins during apoptosis. A turn - off mechanism fo r anti - apoptotic signals."  J Biol Chem   273 (12): 7141 - 7.   Woo, M., R. Hakem, et al. (2003). "Caspase - 3 regulates cell cycle in B  cells: a consequence of substrate specificity."  Nat Immunol   4 (10):  1016 - 22.   Yamaguchi, J., K. F. Kusano, et al. (2003). "Stromal  cell - derived factor - 1  effects on ex vivo expanded endothelial progenitor cell recruitment  for ischemic neovascularization."  Circulation   107 (9): 1322 - 8.   Yang, J. T., H. Rayburn, et al. (1993). "Embryonic mesodermal defects in  alpha 5 integrin - deficient mice ."  Development   119 (4): 1093 - 105.    7. Bibliography     82     Yang, J. T., H. Rayburn, et al. (1995). "Cell adhesion events mediated by  alpha  4  integrins  are  essential  in  placental  and  cardiac  development."  Development   121 (2): 549 - 60.   Yao, J. S., W. Zhai, et al. (2006). "Interleukin - 6  triggers human cerebral  endothelial cells proliferation and migration: the role for KDR and  MMP - 9."  Biochem Biophys Res Commun   342 (4): 1396 - 404.   Yin, A. H., S. Miraglia, et al. (1997). "AC133, a novel marker for human  hematopoietic stem and progenitor cel ls."  Blood   90 (12): 5002 - 12.   Yokoi, N., K. Komeda, et al. (2002). "Cblb is a major susceptibility gene  for rat type 1 diabetes mellitus."  Nat Genet   31 (4): 391 - 4.   Zandy, A. J., S. Lakhani, et al. (2005). "Role of the executioner caspases  during lens developm ent."  J Biol Chem   280 (34): 30263 - 72.   Zemani, F., J. S. Silvestre, et al. (2008). "Ex vivo priming of endothelial  progenitor cells with SDF - 1 before transplantation could increase  their proangiogenic potential."  Arterioscler Thromb Vasc Biol   28 (4):  644 - 50.   Zeng, S., Z. Xu, et al. (2005). "Regulation of stem cell factor receptor  signaling by Cbl family proteins (Cbl - b/c - Cbl)."  Blood   105 (1): 226 - 32.   Zermati, Y., C. Garrido, et al. (2001). "Caspase activation is required for  terminal erythroid differentiation."   J Exp Med   193 (2): 247 - 54.   Zhang, B., Y. Zhang, et al. (2003). "Caspase 3 - mediated inactivation of  rac  GTPases  promotes  drug - induced  apoptosis  in  human  lymphoma cells."  Mol Cell Biol   23 (16): 5716 - 25.        Lebenslauf                             Dörte Scharner         Calvinplatz 1     63263 Neu - Isenburg   Tel: 06102 / 294026   Email: Doertescharner@web.de     geboren   am  01.01.1980  in  Stralsu nd   ledig                     Schul - und Hochschulausbildung       s eit  Okt ober   2005   Promotion   an der  Universität Frankfurt   „ The  n on - apoptotic  function  of  Caspase - 8  in  endothelial precursor cells “   Die  Arbeit  wurde  am  Inst itut  für  Molekulare  Kardiologie  unter  der  Leitung  von   P rof.  Dimmeler,  Johann - Wolfgang  Goethe  Universität  Frankfurt am Main  durchgeführt.       Okt ober  1999   –  Juni 2005   Biologie  an der Justus - Liebig - Universität Gießen       Abschluss: Zellbiologie, Genetik, Biochemie   Diplom - Biologin, Note:  1.5     Thema der  Diplomarbeit:     „Analyse  von  Protein - Protein  Interaktionen  des  multifunktionellen  Transkriptions faktors  CTCF“  am  Institut  für  Genetik  an  der  Justus - Liebig - Universität Gießen/ Prof. Dr. Rainer Renkawitz     1986  -  1998   Grundschule  und  Gymnasium  Barth   m it  Abschluss  der    Allgemeinen  Hochschulreife   Note: 2.9    Vorträge und Posterpräsentationen     November 200 7   Teilnahme mit Pr ä sentation am American Heart  Association Kongress   -  Orlando     “ Caspase - 8 - dependent  cleavage  of  the  E3  ubiquitin  ligase  Cbl - b  regulates  integrin  expression and adhesion capacity in endothelial  progenitor cells”   April 2007   Teilnahme  mit  Präs entation  an  der  73.  Jahrestagung -   Deutsche  Gesellschaft  der  Kardiologie -  Mannheim     „ Caspase - 8  degradiert  die  E3  Ubiquitin - Ligase  Cbl - b  und  reguliert  dadurch  die  Integrinexpression  und  Adhäsion  endothelialer  Progenitorzellen“   November 2006   Teilnahme mit Prä sentation am American Heart  Association Kongress   -  Chicago     “ A novel apoptosis - unrelated role of caspase - 8 in  endothelial progenitor  cell - mediated  n eovascularization”   September 2006   Second  European  Vascular  Genomics  Network  Summer  School  mit  Posterpräsenta tion -   Erice/  Italy        Publikationen     Scharner D , Rössig L, Carmona G, Chavakis E, Urbich C, Fischer A, Kang TB,  Wallach D, Chiang YJ, Deribe YL, Dikic I, Zeiher AM, and Dimmeler S.   Caspase - 8 is involved in neovascularization - promoting progenitor cell  func tions.  Arteriosclerosis, Thrombosis, and Vascular Biology  (ATVB);  2009       Knoblauch M, Noll GA,  Muller T, Prufer D, Schneider - Huther I,  Scharner D , Van  Bel AJ, Peters WS.     ATP -   independent contractile proteins from plants .    Nature Material ;  2003      Eidesstattliche Erklärung     Ich  versichere  an  Eides  statt,  dass  ich  die  vorliegende  Arbeit  eigenständig  ausgeführt und keine anderen als die angegebenen Hilfsmittel verwendet habe.     Alle  Stellen,  die  im  Wortlaut  oder  Sinn  entsprechend  aus  anderen  Arbeiten  ü bernommen wurden, habe ich mit Quellenangaben als Zitat kenntlich gemacht.     Diese  Arbeit  wurde  in  dieser  oder  veränderter  Form  keiner  anderen  Prüfungsbehörde vorgelegt.     Frankfurt am Main, den 09.03.2009                                             Dörte Scharner  